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ABSTRACT 
Lipid membranes play a vital role in cell signaling processes. Membrane shape 
and lipid content affect interactions between cellular membranes and proteins. This 
research focuses on characterizing those interactions and their impact by using various 
biochemical and biophysical assays. These assays were applied to C-reactive protein 
(CRP), an immune system protein that interacts with lipid membranes and has at least 
two forms with different properties. Native, pentameric CRP (pCRP) is found in blood 
serum and is commonly used as a marker for inflammation. The modified form of CRP 
(mCRP) binds to the protein C1q, which activates the complement immune response. 
There is a gap in our knowledge of the biochemical information for the two forms of CRP 
and several different methods are used to make mCRP in the lab. In this work, we  
analyzed the pCRP to mCRP conversion using three biochemical denaturants: guanidine 
hydrochloride, urea with ethylenediaminetetraacetic acid (EDTA), and heating with 
dilute sodium dodecyl sulfate (SDS). After comparing results from biochemical assays to 
determine structural and functional differences, mCRP treated with dilute SDS and heat 
was the form that both significantly bound C1q and had an intrinsic tryptophan 
fluorescence level as anticipated for an intermediate form. 
After characterizing biochemical differences between functional mCRP and 
native pCRP forms, binding of pCRP and mCRP to curved membranes was analyzed 
with an in vitro membrane mimic assay that starts with a nanoscale pattern on a glass 
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coverslip to create curvature for a supported lipid bilayer to coat. By using fluorescent 
nanoparticles of a specific size, curvature based interactions can be visualized and 
quantified. Results show that the amount of CRP binding is not only dependent on 
protein conformation but also on membrane curvature size. 
Expanding the membrane curvature assay, used to visualize CRP membrane 
binding, to allow for cellular experiments was achieved by first melting the nanoparticles 
and then coating them with silicon dioxide, creating a permanent nanoparticle patterned 
substrate. Custom chambers were created and added to the nanoparticle patterned 
coverglass to reduce the required volume. Characterizations of the silicon dioxide coated 
surface were done with analysis of fluorescent lipids in supported lipid bilayers. The 
assays and results from this research not only contribute to better biochemical knowledge 
of CRP, but will be useful for future studies of proteins involved in cellular processes that 
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CHAPTER ONE: INTRODUCTION 
Molecular interactions on a cellular level are directly related to function. While 
some molecular interactions have been well studied and characterized, others still need 
extensive research. Of particular interest are interactions between immune system 
proteins and cells or bacteria that cause a clearance response. Improper clearance can be 
the cause of health problems, e.g. the buildup of atherosclerotic plaque leading to heart 
disease. Besides immune pathways, there are other pathways in the cell that are 
dependent on protein and membrane interactions. Examples include clathrin-dependent 
endocytosis, the SNARE protein complex interacting with synaptic vesicles, and the 
binding of microtubule associated proteins. Working to understand the steps of cellular 
pathways on a molecular level not only increases biochemical knowledge, but also brings 
medical insight that can lead to future treatments for diseases impacted by interaction 
problems. 
In this work, the binding interactions of C-reactive Protein (CRP), a member of 
the innate complement immune response, were characterized. CRP interacts both with 
lipid membranes and protein partners, and all these interactions depend on the 
conformational state of CRP. To assess these interactions, it was first necessary to 
determine a method for making a modified CRP conformational state in the lab. This 
CRP conformer was characterized and tested for biological relevance using a protein 
binding assay. To identify CRP-lipid interactions, the two CRP conformational states 
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were used in a membrane curvature binding assay with different curvature sizes and lipid 
compositions. Beyond the characterization of CRP interactions, the work herein describes 
advancements to the curved membrane binding assay, specifically the addition of custom 
made chambers reducing the volume and the use of silicon dioxide coated melted 
nanoparticles for permanency. These substrates can be used for both supported lipid 
bilayers and for cellular assays in future research projects. 
1.1 Lipids and Membranes  
Lipids play an important role in cellular and organelle membranes both 
functionally and structurally. Model membranes are commonly used to study lipid and 
membrane properties. Each lipid membrane assay used in the lab can be broken down 
into one of three formation categories: micelles, liposomes, and bilayers, the third 
category applies to the work presented here. An early assay for lipid studies is 
Langmuir’s film balance for measuring surface tension (1). Initial work with liposomes, 
originally referred to as phospholipid spherules, focused on how steroids, antibiotics, 
detergents, etc. would either stabilize or disrupt the liposome structures (2).  
While preliminary studies focused on characterizing lipid membranes, usually 
from methods that involved fractionating cells (3), current research utilizes bilayers and 
liposomes with both cellular and artificial membranes to study the interactions of those 
membranes. Advancements in cellular membrane isolation have allowed for most of the 
plasma membrane proteins and lipids to remain intact. One technique involves starting 
with cells that have been stuck to a glass surface and then disrupting them with a 
sonicator so that sheets of plasma membrane are left behind and other cellular 
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components are washed off (4). Since transmembrane proteins are still present, it is 
possible to use this model to do assays of complex membrane functions, such as 
endocytosis (4). 
Although the membrane sheet model is useful for assays that require 
transmembrane proteins and various lipids to be present, the complexity of the cell 
membrane can make it difficult to identify the exact lipid-protein interaction that is taking 
place. Simple lipid bilayers can be made using a technique referred to as supported lipid 
bilayers (SLB). The process starts with creating liposomes out of the lipid mixture and 
depositing them onto a surface, a process that depends on the conditions and charge of 
the vesicle (5). If specific sizes of liposomes are needed, lipids are extruded through 
polycarbonate membrane filters (6). Different conditions can cause the liposomes to split 
open and lay flat so they form a bilayer when attaching to the surface, to form a vesicular 
layer, or to fail to attach. Although the term attach is being used to describe the liposomes 
and SLB interacting with the surface, there is a small layer of water ranging from 0.5-1 
nm cushioning the lipids (7). Calcium ion concentration is important for negatively 
charged and zwitterionic liposomes to form SLBs (5). To introduce features into bilayers, 
SLBs can be formed on top of flat cover plates, lithographed textured surfaces, and plates 
that have areas with nanoparticles (either set on top or partially melted onto the surface) 
(8, 9). These options for studying flat and curved interactions, as well as the ability to 
vary the lipid mixture and proteins present, make SLBs a versatile tool for studying 
interactions between curved membranes, lipid composition, and/or proteins. 
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1.2 Protein-Lipid and Lipid-Membrane Interactions 
Interactions being studied between proteins and membranes with a SLB type of 
assay usually involve peripheral membrane proteins, which interact with the cell 
membrane surface either through specific headgroup binding or through insertion of the 
peripheral protein into the membrane (hydrophobic interactions). Binding of certain 
peripheral proteins to specific lipids can cause activation or inhibition of cellular 
processes (10). 
Besides SLB membrane assays, other assays used to study protein-lipid 
interactions include surface plasmon resonance, circular dichroism, electron 
paramagnetic resonance spectroscopy, and Fourier transform infrared spectroscopy (11). 
Fluorescence techniques can also be used for studying peripheral membrane protein 
interactions with lipids. Fluorescence recovery after photobleaching (FRAP) on lipid 
tethers from giant unilamellar vesicles has been used to study interactions of endophilin, 
an N-BAR domain protein involved in clathrin-mediated endocytosis, with curvature on a 
tubular membrane (12).  
The idea that BAR domains and other peripheral membrane proteins can sense 
regions of curvature suggests that there are specific regions where certain lipids and 
proteins are favored. Lipid and protein sorting can be attributed to lipid microdomains or 
membrane shape. Lipid rafts were originally envisioned as a way to explain the delivery 
of lipids selectively to the apical or basolateral surfaces of an epithelial cell (13). Lipid 
raft models are usually done on a larger scale to study their effect; however, in cells, lipid 
rafts are proposed to be less than 10 nm in diameter. Despite these differences, both in 
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vitro and in vivo models have benefitted from the idea of lipid rafts for studying lipid 
domains, which have high concentrations of cholesterol and sphingolipids. 
One proposed mechanism for lipid sorting into microdomains as well as areas of 
curvature is by the intrinsic shape of the molecule, based on the concept that molecules 
will favor locations where they minimize loss of energy due to spaces between lipids. A 
lipid may favor a particular curvature based on head or tail shape or size as seen in 
studies of simulated self-assembly of lipids with different head sizes (14). Despite these 
calculations, other research has not shown lipid sorting based on molecular shape (15). 
There is a proposed mechanism of proteins recognizing defects in the lipid membrane, 
which are found at regions of curvature, with the example of crescent-shaped BAR 
domains binding at curved membranes (16). 
1.3 C-Reactive Protein 
Besides BAR domains, there are many other proteins that bind to membranes as 
part of cellular processes. One such protein is C-reactive protein (CRP), an immune 
system protein involved in inflammation and clearance. CRP has been shown to bind to 
lipids on highly curved low density lipoprotein (LDL) mimics made from liposome 
coated gold nanoparticles (17). Binding of CRP to LDL in the body would likely activate 
the classical complement pathway, tagging LDL for clearance. 
1.3.1 CRP and the Classical Complement Immune Response 
Due to its role in the classical complement pathway and apoptosis, it is not 
surprising that CRP is found all over the body, despite being produced mainly in 
hepatocyte cells. Normal levels of CRP are considered to be around 0.8 mg/L, however, 
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during inflammation CRP levels can increase rapidly and reach 1000 fold in 48 hours 
(18). When bacteria or apoptotic cells are present, the circulating CRP binds to their cell 
membranes. CRP has established interactions with phosphocholine, which is found on a 
number of bacterial and eukaryotic membranes (19). CRP is known to bind to apoptotic 
cells in the presence of Ca2+, and C1q, a protein with a collagen-like stem and six head 
groups (20), is required for clearance of those cells (21). When C1q binds to CRP, the 
classic complement pathway (Figure 1) is activated, ending with the membrane attack 
complex creating pores in the membrane allowing the flow of fluid and ions and the cell 





Figure 1. Diagram overview of the classical complement pathway with CRP activation. CRP first 
binds to the membrane and then recruits C1q. Once the rest of the C1complex binds, the classical 
complement pathway is activated, ending with cell lysis from the membrane attack complex (20). 
Factor H inhibits the classical complement pathway and leads to the alternative pathway, ending 
in phagocytosis. 
Beyond this role with C1q in the classical complement pathway, CRP has been 
found to promote phagocytosis (functioning as an opsonin) through recruitment of Factor 
H, which is a regulator of the complement system (22). CRP gene expression is regulated 
Bacterial or apoptotic cell 
membrane
mCRP binds to the 
membrane
C1q binds to mCRP





protein binding and 
convertase activity forms 
the membrane attack 
complex




by interleukin-6 (IL-6), which controls the expression of many acute phase proteins. CRP 
has pro-inflammatory and anti-inflammatory features, which are predicted to be from the 
pentameric (pCRP) and modified (mCRP) conformers, respectively (23, 24). With the 
multiple features of CRP, it is no surprise that in addition to being produced in hepatocyte 
cells, CRP synthesis has been discovered in atherosclerotic plaques, lymphocytes, 
monocytes, and neurons.  
1.3.2 CRP and Cardiovascular Disease 
Of all the areas of the body where CRP is found, the location of atherosclerotic 
plaque is of particular interest due to a link between high CRP levels and cardiovascular 
disease (CVD) risk (19, 25, 26). Elevated CRP levels can be caused by acute infection or 
a chronic illness. If the inflammation decreases with time or treatment, the CRP levels 
should return to a normal range. Inflammation of the endothelium can cause 
atherosclerosis due to the expression of adhesion molecules (27), indicating that some 
types of inflammation can trigger plaque formation. Furthermore, some treatments for 
CVD, such as statins to lower cholesterol, have been shown to decrease inflammatory 
markers such as CRP. 
Inflammation is a major part of atherosclerosis, regulating the protective fibrous 
cap and the plaque thrombogenicity (27–29). Atherosclerotic plaque contains the mCRP 
conformer, as measured by antibodies that bind specifically to the modified form. In 
contrast, healthy vessels have neither form of CRP, and pCRP is found in serum (23). 
Research suggests that conversion of pCRP to mCRP is localized to inflamed endothelia, 
and plays a vital role in atherogenesis (30). A necessary process of clearing LDL from 
 
 9 
plaques involves the transformation of macrophages into foam cells. CRP has been found 
to assist macrophages in taking up native LDL and becoming foam cells (31). Initially a 
rise in CRP levels should help clear atherosclerotic plaques. However, if the recruitment 
of Factor H by CRP is high, then C3 convertase formation will be blocked, which 
prevents the membrane attack complex from being formed as well as opsonins (20). This 
prevention may leave cells in a necrotic or semi-apoptotic state without phagocytosis to 
completely clear out debris.  
CRP is known to bind to apoptotic cell membranes (19, 23, 32) and the contents 
of the core of atherosclerotic plaque include uncleared apoptotic cells as well as mCRP 
(23, 33). Characteristics of apoptotic cells that could induce binding include membrane 
shape and lipid composition (blebbing, phosphatidylserine or oxidized lipids being 
present) (34, 35). Apoptotic cells have been shown to convert pCRP to mCRP (23). 
However, it is unclear if mCRP takes the form of a monomer, loose pentamer, or 
oligomer (36, 37). Research in this field has been hampered due to the absence of 
information regarding what triggers conversion in biological systems. The results from 
the experiments outlined below contribute to a better knowledge of the pCRP and mCRP 
conformational states and their interactions with curved membranes. 
As mentioned above, CRP has been shown to bind highly curved LDL mimics 
(38), and LDL may play a role in atherosclerosis and CRP conversion (39). In these 
studies, pCRP binds preferentially on LDL mimics with a diameter less than 28nm, 
converts to mCRP, and can bind C1q (40). CRP recognizes membrane curvature, and 
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membrane shape is able to cause conformational changes in the absence of lipid 
oxidation or other proteins (38). 
Current literature is unclear on the precise interactions of mCRP and pCRP at 
sites of inflammation with other inflammatory components. The research performed here 
includes an in vitro assessment of specific interactions of conformers with membrane 
curvature and lipid composition. A strength of the membrane curvature assay is the 
unique ability to isolate components involved in apoptotic membranes and analyze the 
binding of CRP in the isolated system. Once individual components are studied, it is 
useful to return to a cellular membrane approach, which can be accomplished with the 









CHAPTER TWO: COMPARISON OF BIOCHEMICALLY PREPARED 
MODIFIED C-REACTIVE PROTEIN 
2.1 Introduction 
C-reactive protein (CRP) is a mediator of inflammation and plays an active role in 
the complement immune response to clear foreign material and apoptotic cells from the 
body (19). The amount of CRP in serum is related to numerous disease states, such as 
coronary heart disease (41), Alzheimer’s disease (42) and autoimmunity (43, 44). In 
many diseases, elevated CRP levels are related to increased risk (i.e. coronary heart 
disease, Alzheimer’s disease) and CRP is often measured as a marker for chronic disease. 
In other diseases (i.e. arthritis, multiple sclerosis) overexpression of CRP in mouse 
models has been shown to be protective (45, 46). Although elevated CRP levels reveal 




Figure 2. pCRP has rotated protomers and PC binding sites, as seen by the secondary structure. 
Secondary structure of pCRP includes α-helices (orange) and β-sheets (purple) along with 
calcium (yellow) dependent PC (blue) to PC binding site (47, 48). Distance from center of PC 
binding between protomers is 4.2 nm. 
Native, pentameric CRP (pCRP) is a stable, soluble, homopentamer present in 
serum. CRP binds to damaged cell membranes and foreign pathogens to activate an 
immune response for clearance (19, 49, 50). It has been proposed that cellular damage 
exposes phosphatidylcholine (PC) headgroups and this allows CRP to bind (19) through 
Ca2+ dependent binding sites present on each monomer (48) shown in Figure 2. Upon 
binding membranes, CRP activation of the complement immune response likely involves 
pentamer dissociation to reveal neoepitopes (23, 36). The new form of CRP is referred to 
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as modified CRP (mCRP), but the precise structure of this conformation is not known. In 
response to the new portions of CRP that are exposed, binding partners, such as C1q, 
recognize CRP and the complement immune response is initiated (51). The majority of 
recent research points to membrane bound CRP binding the globular head region of C1q 
(32, 50, 52, 53). However, mCRP has been shown to bind both the globular head and 
collagen-like region, with higher binding for the collagen-like region (50). To activate 
C1q, it is predicted that multivalent binding needs to occur through the globular heads 
(54). In the pentameric state the pCRP presents only one binding site for the large C1q, so 
multiple copies are needed (53). One pentamer that dissociates into membrane bound 
mCRP could lead to multivalent C1q binding. In support of this, other studies have 
shown that the native form of CRP is incapable of binding C1q and a modified form is 
required (32, 55). 
 
Figure 3. Binding sites of CRP ligands. Two orientations of pCRP and mCRP showing PC bound 
near the top of the monomer. The cholesterol binding sequence (56) is highlighted in magenta in 
both structures and the amino acids residues thought to bind C1q are highlighted in yellow on the 
monomer (53). Imaging utilized UCSF Chimera software with the 1B09 CRP protein data bank 
file (47, 48). 
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The conformation of CRP affects biochemical reactivity and likely has different 
physiological effects (57). In most patient studies, the soluble, pentameric form of CRP is 
measured, but there is clear evidence that the conformational state of CRP affects 
function (32, 37, 58, 59). Multiple forms of CRP have been measured in patient samples, 
where atypical forms of CRP were identified in patient serum by gel electrophoresis and 
correlated to obesity (60). Modified forms, as recognized by antibodies that are specific 
for epitopes that are not exposed in pCRP, have also been found in plaque (23), 
suggesting an active role of modified CRP in cardiovascular disease. 
The causes and effects of CRP conformational changes are not well understood. 
Proposed causes of conformational change include membrane binding to specific lipids 
and/or the presence of an acidic environment, like those at sites of inflammation (61, 62). 
Membrane shape may also play a role in CRP conformational change since certain forms 
of CRP have curvature preferences (38, 63). In general, binding to membranes likely 
stabilizes the transition from a pentamer to monomer by allowing for insertion into 
membranes to stabilize hydrophobic portions of the protein, like the cholesterol binding  
domain (64), that are newly exposed in the transition from p to m. 
The main purpose of this work was to design a method for CRP conversion in the 
laboratory and an assay for creating a form of CRP that mimics mCRP activity. Since one 
physiological purpose of CRP is to activate C1q, we have chosen our readout for making 
an active, modified form of CRP as one that can bind C1q. To determine the best method 
for CRP conversion, we built upon the work of others where mCRP was made 
biochemically with 8 M urea and 10 mM EDTA  (32, 58, 64–66), with Guanidine HCl 
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(67) or by dilute SDS and heat (40, 59). We compared a variety of methods for 
synthesizing mCRP from serum purified pCRP and then tested each method for the 
ability to produce a form of CRP that: 1) runs differently than pCRP on a non-denaturing 
polyacrylamide gel and 2) binds C1q, one downstream binding partner of CRP in the 
complement immune response. The change in conformation was also assessed by 
tryptophan (Trp) and 1-anilinonaphthalene-8-sulfonic acid (ANS) fluorescence, which 
show clear differences in conversion methods for mCRP. These methods build upon the 
work of others that have characterized CRP states by non-denaturing PAGE methods (59) 
and adds functional relevance through ELISA based assays with C1q. We conclude that 
dilute SDS/heat treated pCRP consistently produces a functional form of mCRP, whereas 




The ANS fluorescence assays were performed by Dr. Aml Alnaas and the circular 
dichroism of CRP was done by Yuheng Cai. The remaining experiments were done by 
Carrie Moon. 
Materials 
C-reactive protein was purchased from Academy Bio-Medical Company (#30P-
CRP110) and stored at 4 °C for up to 6 months. Standard CRP concentration used was 
57.5 μg/mL unless otherwise noted. C1q was purchased from Complement Technologies 
(#A099). Standard buffers used for the majority of these experiments were 30 mM 
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HEPES or PIPES (J.T. Baker), 2 mM calcium chloride, 140 mM sodium chloride, pH 
6.4. Chemicals were purchased from Thermo Fisher Scientific or Sigma Aldrich unless 
otherwise noted. Stock denaturant solutions of 6 M GndHCl and 8 M urea, 10 mM 
ethylenediaminetetraacetic acid (EDTA) were made in standard buffer (pH 6.4). GndHCl 
and urea CRP conversion samples were allowed to incubate for 2 hours at room 
temperature prior to analysis. Dilute sodium dodecyl sulfate (SDS) treated mCRP was 
made by combining CRP in standard buffer with 0.01% SDS and heating for 1 hour at 80 
°C (40). All error values are standard error of the mean. 
Structural Analysis 
The published crystal structure of CRP with bound PC was used for all structural 
illustrations and analysis (48). Renderings were done using the UCSF Chimera software 
(47). 
Non-denaturing PAGE 
CRP forms were visualized using a non-denaturing polyacrylamide gel 
electrophoresis (PAGE) assay previously established (40) Standard Laemmli conditions 
were followed (68) with the exception of using 0.005% SDS in the gel and using native 
sample buffer (no SDS, β-mercaptoethanol, or heat). These modifications ensured a non-
denaturing gel. Standard tris-glycine running buffer containing 0.1% SDS was used. The 
amount of CRP loaded into each well was 0.43 μg. Gels were run at 80 V for 2 hours and 
then silver stained. Relative molecular weights for denatured proteins were marked for 
comparison by using Precision Plus Dual Color Standards (Bio-Rad #1610374). Gels 
shown are representative of at least 4 experiments. 
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Tryptophan Fluorescence Spectroscopy 
All fluorescence measurements were measured in a Tecan Infinity M1000 Plate 
Reader using black polystyrol half area 96 well plates (Corning #3694). The intrinsic 
fluorescence of CRP was measured using 57.5 µg/mL of CRP, which was compared with 
3.06 µg/mL tryptophan (the equivalent concentration for the amount of CRP used based 
on 6 tryptophan residues per monomer). Excitation wavelength was 280 nm with a 
bandwidth of 2.5 nm. Emission spectra were collected from 300-400 nm with a step size 
of 5 nm and a bandwidth of 5 nm (Figure 4). The fluorescence intensity from 300-400 nm 
was integrated and then each value was normalized to the integrated pCRP intensity. Data 
points were not included when they fell more than two standard deviations from the mean 
value. The GndHCl denaturation curve was fit to the following equation (69):  
F =











Where F is measured fluorescence, FN, and FU are the fluorescence of the native 
state, and the unfolded state, respectively. The slopes are for the native (mN) and unfolded 
(mU) states of the protein. [D] is the concentration of denaturant. ΔG°N/U is the Gibbs free 
energy of unfolding. R is the universal gas constant (8.314 J mol-1 K-1) and the 




Figure 4. Sample fluorescence spectra from pCRP and mCRP made with SDS and heat. Data 
from each spectrum was integrated from 300 to 400 nm to give a single value for each well, those 
values were normalized to the pCRP value for that day. Combined data is plotted with averages 
and SEM in Figure 5 and Figure 7. 
Dynamic Light Scattering 
Dynamic light scattering (DLS) was performed on a DynaPro Plate Reader II with 
Dynamics version 7 software (Wyatt Technology) using a 384 well glass bottom plate 
(Greiner Bio-One Sensoplate #781892). CRP (500 µg/mL in pH 6.4 PIPES buffer, details 
above) was placed into 4 wells for measurements (50 µL). The plate was centrifuged at 
200 rpm for 2 min. Readings were performed at 25 °C using a 5 s acquisition time with 
auto-attenuation. The solvent setting for the system used was based on phosphate 
buffered saline with a refractive index of 1.333 (at 589 nm for 20 °C) and a viscosity of 
1.019 cP. Each well had 10 acquisitions. A Rayleigh spheres model was used to fit the 
data with the Dynamics software. 
Circular Dichroism 
CRP samples of pCRP and mCRPHeat were prepared for circular dichroism (CD) 
by dilution in standard HEPES buffer at pH 7.4 to a concentration of 19.6 µg/mL. Dilute 























SDS samples contained 19.6 µg/mL of CRP in phosphate buffer (10 mM disodium 
phosphate, 2.7 mM potassium chloride, 1.8 mM monopotassium phosphate, 1 mM 
calcium chloride, pH 7.6) with 0.005% SDS. CD spectra from 207-250 nm was recorded 
using a JASCO J-1500 Circular Dichroism Spectrometer. Samples with SDS were heated 
and measured at 5-degree intervals from 20 to 80 °C and then allowed to cool to room 
temperature (20 °C) before the final scan. Background CD spectra from buffers was 
subtracted for all samples. 
ANS Fluorescence Assay 
1-Anilinonaphthalene-8-sulfonic acid (ANS), a hydrophobic fluorescent probe 
purchased from Cayman Chemical (Ann Arbor, MI), was used to monitor the 
conformational changes of CRP after treating the protein with different denaturants. The 
stock solution of 100 mM ANS was dissolved in DMSO and diluted to a final 
concentration of 190 μM with Millipore water. CRP (50 μg/mL) was incubated with the 
GndHCl or urea/EDTA denaturants in HEPES buffer (pH 6.4) for 2 hours at 37 °C. 
Dilute SDS CRP samples were heated for 1 hour at 80 °C with 0.01% SDS in HEPES 
buffer (pH 6.4). The control pCRP sample was diluted in TBS buffer (50 mM Tris-HCl, 
150 mM NaCl, 0.1 mM CaCl2, pH 7.2). Fluorescence intensity of ANS was measured 
using an excitation wavelength of 390 nm, and emission spectra were measured from 440 
nm to 650 nm. The same plate reader and plates listed above in tryptophan fluorescence 
were used for ANS experiments. 
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Enzyme Linked Immunosorbent Assay (ELISA) 
The binding of CRP to C1q was measured by performing an ELISA with C1q as a 
capture at a concentration of 1 µg/mL, following previously published procedures (40). 
Bovine serum albumin (BSA, 1 µg/mL) was used as a control in place of the C1q 
capture. BSA or C1q were diluted in coating buffer (30 mM sodium carbonate, 70 mM 
sodium bicarbonate, pH 9.6, Sigma Aldrich). 100 µL of coating solution was added to the 
microwells in a Microlon 600 96W high binding clear microplate (either Greiner 
Bioscience 655081 or Nunc Maxisorp Immuno Plate 446612). Control wells were tested 
with plain coating buffer (no protein) which resulted in similar results as with BSA due to 
the BSA block. Fish gelatin at 3% was tested as an alternative blocking agent, however 
since this failed to block non-specific binding, BSA or fatty acid free BSA was used as a 
blocking agent. After a 2 hour incubation at 37 °C or an overnight incubation at 4 °C, 
wells were washed three times with 300 µL of phosphate buffered saline with 0.05% 
Tween-20 (PBST; Acros Organics) and once with 300 µL of phosphate buffered saline 
(PBS). Next, 300 µL of blocking buffer (3% w/v BSA in PBST) was added and the plate 
was incubated at room temperature for 2 hours. In between each step in the assay, wells 
were washed as described above (three times with PBST and once with PBS). 100 µL of 
CRP (1.8 µg/mL) in diluting buffer (1% w/v BSA in PBS) was added and incubated for 1 
hour at 37 °C. The antibody, a biotinylated polyclonal anti-CRP (Academy Biomedical 
Co. #CRP30BG1), was diluted at a ratio of 1:5,000 in diluting buffer and 100 µL was 
added and incubated for 1 hour at 37 °C. After washing, 100 µL of a 1:10,000 dilution of 
HRP-Strep was added to each well and incubated for 30 minutes at 37 °C. A final wash 
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sequence was followed by the addition of 100 µL of 3,3’,5,5’-tetramethylbenzidine 
(TMB) substrate. After the color was allowed to develop (5-10 min) at room temperature, 
the reaction was stopped by the addition of 100 µL of 0.5 M sulfuric acid, turning the 
reaction solution from blue to yellow. Absorbance was measured at 450 nm, with a 
reference absorbance of 620 nm on a Microplate reader (Tecan infinite-M1000 PRO). 
Data was normalized by day to either 0 M denaturant (pCRP) or mCRP with SDS and 
heat absorbance values. 
2.3 Results 
To determine the stability of the native, pentameric form of CRP, we denatured 
CRP using two common denaturants, urea/EDTA and GndHCl. The intrinsic tryptophan 
fluorescence was measured and found to decrease with increasing denaturant, as 
expected, for most concentrations (Figure 5A and Figure 5B). The change in fluorescence 
occurs as some of the 6 Trp residues (per monomer of CRP) go from a hydrophobic 
protein environment to a more aqueous environment. Denaturation with GndHCl led to a 
clear transition (Figure 5A) between 2 and 2.75 M GndHCl, however, the gradual decline 
in fluorescence from 0 to 2 M suggests conformational changes are occurring even at low 
concentration. Interestingly, tryptophan fluorescence increases at GndHCl concentrations 
higher than 4.25 M (see Figure 6A), so only data ≤ 4.25 M GndHCl was used for fitting. 
A slight change in the appearance of the band with non-denaturing gel is observed at 
higher concentrations of GndHCl (Figure 6B). The change in fluorescence was fit, as 
described in the methods, to give a Gibbs free energy of unfolding (ΔG°N/U) of 32 ±12 
kJ/mol and a m value of -13 ±5 kJ/mol. With a weaker denaturant, urea/EDTA, the 
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decrease in fluorescence is more gradual and lacks a clear transition. If pCRP was 
completely denatured, the expected Trp fluorescence would be equal to the same amount 
of free Trp in buffer. The integrated fluorescence intensity for free tryptophan based on 
the concentration of CRP present was measured in the denaturants for comparison with 
CRP samples, as shown in Figure 5A, Figure 5B, and Figure 7C. It is interesting to note 
that the tryptophan fluorescence of CRP treated with 4 M GndHCl falls below that of free 









Figure 5. Intrinsic fluorescence and non-denaturing PAGE assays of CRP treated with GndHCl 
and urea. Intrinsic, tryptophan fluorescence was measured by exciting solutions at 280 nm and 
recording fluorescence from 300-400 nm for both GndHCl (N=8, A) and urea/EDTA (N=10, B) 
treated CRP (black filled circles) as well as select concentrations for free tryptophan (open 
circles). The integrated fluorescence was normalized to the 0 M denaturant data point. The solid 
line in A is a fit used to determine the energy of unfolding as described in the Experimental 
Procedures. Error bars are ± SEM. Non-denaturing PAGE of CRP treated with GndHCl (C) and 
urea/EDTA (D) after two hours of incubation. The ladders shown are SDS-PAGE (denatured) 
protein standards for relative molecular weight comparison. Gels shown are representative of at 
least 4 experiments. 
After measuring the intrinsic fluorescence to identify changes in the exposure of 
Trp residues to an aqueous environment, samples were loaded onto a non-denaturing 
polyacrylamide gel to assess the presence of different states of CRP. Non-denaturing gel 
conditions were used because mCRP fails to appear under native gel conditions that 
contained no SDS, which has been confirmed by others (59). Both the molecular mass 
and the charge affect migration in this assay. In Figure 5C and D, a clear transition occurs 
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where a modified form of CRP begins to show, running similar to the 20 kDa standard. 
Although the gels shown in Figure 5 appear to have slightly different running distances 
for the mCRP band, comparisons of all gels run do not show a consistent difference. With 
GndHCl treatment, this band first shows up at 1.75 M GndHCl and is fully present at 
2.75 M, matching the profile of intrinsic fluorescence in Figure 5A. When pCRP is 
treated with urea/EDTA, a clear transition exists in the gel from 2.25 to 4.00 M urea. The 
mCRP band increases over this range and the pCRP (not shown but retained in the 
stacking portion of the gel) disappears. pCRP is a 115 kDa pentamer with a pI of 6.4 that 
changes to 5.6 upon monomerization with urea (67). The pentameric form has less charge 
density, is larger, and therefore does not run well into the gel. A haze of protein is also 
observed in the gel and this fully disappears at 4.00 M. This could be due to alternative 
states of pCRP that have not been fully characterized and these are present in the absence 
of urea (Figure 5D, 0.00 M). 
 
Figure 6. Higher concentrations of GndHCl lead to changes in intrinsic tryptophan fluorescence 
and non-denaturing gel bands. A) The integrated, normalized tryptophan fluorescence of GndHCl 
treated CRP (black filled circles), N=8. Free tryptophan was measured for pCRP (0 M GndHCl) 
and 4 M GndHCl treated CRP (open circles), N=9. All error is SEM. B) Non-denaturing PAGE 
of higher GndHCl concentrations with shift in bands of mCRP at higher concentrations. Gel is 
representative of 4 gels.  
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To determine if other denaturants can be used to make a functional form of 
mCRP, dilute amounts of detergent (SDS) were tested along with heat. Non-denaturing 
PAGE reveals a band around 20 kDa for mCRP made from exposure to 0.01% SDS with 
heat and a high band for pCRP (Figure 7A). Since pCRP remains in and near the stacking 
portion of the non-denaturing PAGE gel, dynamic light scattering (DLS) was used to 
confirm that pCRP is not aggregating. 99.85% ± 0.09 of the results for the hydrodynamic 
radius fell between 0 and 10 nm, with an average radius from that range is 4.12 ± 0.15 
nm (Figure 7B). DLS with SDS and heat treated mCRP gave results that indicated 
aggregation due to the high concentration (500 µg/mL) needed to run the experiment. 
The different properties of dilute SDS and heat treated CRP are evident when free 
tryptophan and CRP levels of all the denaturants are compared. Only mCRP made with 
SDS and heat has a normalized integrated fluorescence between the pCRP and free 






Figure 7. Dilute SDS with heat treatment leads to monomeric CRP. A) Non-denaturing PAGE of 
pCRP and CRP heated with 0.01% SDS (mCRP) demonstrates that the two forms have different 
electrostatic properties. B) Data on the graph is from the 0-10 nm radius range and represents 
99.85% ± 0.09 mass detected by dynamic light scattering. Average radius measured is 4.12 ± 
0.15 nm. C) Comparison of intrinsic tryptophan fluorescence for pCRP and SDS with heat mCRP 
with fluorescence of free tryptophan. Normalized to pCRP, N=9. All error is SEM. 
 




Circular dichroism (CD) was used to measure CRP during the denaturation 
process to assess whether conformational changes were occurring to the secondary 
structure. pCRP and mCRP have a different CD signal from 210 to 230 nm with a dip for 
pCRP (Figure 9A). Although there is a different CD signal for pCRP and mCRP forms, 
the two methods tested for mCRP – with dilute SDS and heat or with just heat – have 
similar spectra. CRP treated with dilute SDS was tested at various temperatures and 
Figure 9B shows full conversion from pCRP to mCRP around 70 °C with a less 
structured spectra. CRP that has been cooled back to room temperature post heating to 80 





Figure 9. Circular Dichroism of CRP forms shows a structural change. A) Circular dichroism 
spectra of pCRP (red line) and mCRP made from heat only (grey line) and dilute SDS with heat 
(red line). B) CRP sample with dilute SDS in buffer heated in the cuvette from 20-80 °C with CD 
spectra recorded and final sample allowed to cool back to room temperature. 
To monitor CRP unfolding after incubation with different denaturants ANS, a 
hydrophobic fluorescent probe, was utilized. ANS is frequently used in biochemistry and 
biophysics research to identify protein folding and aggregation. ANS binds to 
hydrophobic regions of proteins, which leads to a significant increase in its quantum yield 
and a blue shift in the emission maxima (70). Previous research has used ANS to 
investigate the conformational changes of CRP at various pH and temperatures (62, 71). 
Because ANS binds hydrophobic regions, an increase in ANS fluorescence indicates that 
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the protein has more hydrophobic regions exposed. As shown in Figure 10, treatment 
with 3 M GndHCl (Figure 10A), 6 M urea (Figure 10B), or 0.01% SDS with heat (Figure 
10C) caused hydrophobic portions of CRP to be exposed. SDS-treated CRP showed the 
largest change (Figure 10C, black circles) from the untreated CRP (grey triangles in all 
figures) compared to other denaturants.  
 
Figure 10. Treatment of CRP with denaturants increases ANS binding. ANS fluorescence upon 
binding to CRP incubated with (A) 3 M GndHCl for 2 hours at 37 °C (black circles), (B) 6 M 
urea/EDTA at 37 °C for 2 hours (black circles), and (C) 0.01% SDS with incubation at 80 °C for 
one hour (black circles). Grey triangles for all are pCRP. N=3 
After altering the conformation of pCRP with urea/EDTA, GndHCl and 0.01% 
SDS with heat, we assessed whether the new forms of CRP could bind C1q, a well-
established binding partner for initiation of the complement immune response. Enzyme-
linked immunosorbent assays (ELISAs) were performed where C1q was used to capture 
CRP. A polyclonal antibody to CRP with a biotin linkage was used to then bind 
horseradish peroxidase linked streptavidin (HRP-Strep). In Figure 11, the GndHCl treated 
CRP clearly shows binding to C1q (black filled circles), however, for most 
concentrations, similar binding was observed for a control, where bovine serum albumin 
(BSA) was used as the capture protein. Statistical significance between BSA and C1q 
binding only exists at 1.5 M GndHCl (p-value of 0.0037 for Student’s paired t-test). Urea 
treated CRP binds BSA comparably to C1q and the binding is not statistically significant 
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(Figure 6B). Acid treated CRP shows similar behavior which indicates that the binding 
observed is not specific (62). However, dilute SDS with heat-treated CRP does have 
significant C1q binding with a p-value of 0.0103 as determined by a two-tailed paired 
Student’s t-test (Figure 11). Table 1 contains a detailed list of all p-values. As pCRP 
converts to mCRP, more amino acid residues are exposed, as well as areas of binding 
sites for ligands (Figure 13 and Figure 3). A summary of the results for each CRP form is 




Figure 11. Denaturation of pCRP by GndHCl, urea/EDTA, or dilute SDS with heat alters CRP 
binding to BSA and C1q. ELISA with BSA (open circles or solid bars) or C1q (filled circles or 
striped bars) as the capture agent was performed to determine if denaturation at a certain 
concentration leads to a form of CRP that can bind C1q. A) CRP treated with 1.5 M GndHCl (or 
higher concentrations) leads to C1q binding, however the binding above 2 M GndHCl is not 
specific; BSA capture works equally well. B) Urea treated CRP binds C1q at 5 M and higher 
concentrations, but also binds BSA non-specifically. Data for A and B was normalized to pCRP 
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(0 M GndHCl or urea). C) C1q captures CRP treated with 0.01% SDS and heated at 80 °C for 1 
hour (solid black), but not pCRP (solid grey) or antibodies (solid light grey). BSA captures 
mCRP significantly less than C1q (black stripes), but captures more 0.01% SDS with heat treated 
CRP than pCRP (grey stripes) or antibodies (light grey stripes). Data was normalized to the 
average mCRP absorbance with C1q capture. Significance was calculated using a two-tailed 
Student’s paired t-test (p-values < 0.05 shown as * and < 0.01 shown as **). Detailed 
significance for C can be found in supplemental Table 1. Error bars are SEM and only shown in 
the positive direction for clarity. Often the SEM is smaller than the data point. 
Table 1. ELISA t-test results. 




C1q-mCRPSDS BSA mCRP 0.0103 * 
BSA pCRP 0.0067 ** 
BSA None 0.0102 * 
C1q pCRP 0.0091 ** 
C1q None 0.0106 * 
C1q-pCRP BSA mCRP 0.5775 NS 
BSA pCRP 0.0014 ** 
BSA None 0.0035 ** 
C1q None 0.6587 NS 
BSA-mCRPSDS BSA pCRP 0.0432 * 
BSA None 0.0629 NS 
BSA-pCRP BSA None 0.2092 NS 
C1q-None C1q BSA 0.0106 * 
C1q- 
CRP1.5M GndHCl 
BSA CRP1.5M GndHCl 0.0037 * 
C1q- 
CRP7M Urea 
BSA CRP7M Urea 0.2972 NS 
 
2.4 Discussion 
CRP is known to have both a pentameric native form and a modified form that 
exposes neoepitopes (55, 67). We confirmed with DLS that purchased pCRP, prior to 
denaturation methods, had a hydrodynamic radius (RH) within range for the pentameric 
state (4.12 ± 0.15 nm, Figure 7B). In comparison, the measured radius from the pCRP 
crystal structure is 5.1 nm (22) and the radius of gyration (Rg) for pCRP is 3.7 nm, as 
determined by x-ray scattering (66). The Rg has a linear relationship to the RH for 
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spheroidal objects that can be summarized by the equation Rg = 0.775 x RH (72). Using 
the RH found by DLS above, our calculated radius of gyration would be 3.19 ± 0.12 nm. 
Since CRP is a disk-shaped pentagon (73) and not a perfect sphere, a slight discrepancy 
between the calculated and observed Rg values is expected. With salt concentrations in 
buffer, CRP is expected to stay as a pentamer and not form a decamer (66). Having 
established that CRP without any denaturant is the native, pentameric form, the next step 
was to produce an in vitro mCRP.  
Denaturants, such as chemicals or heat, have a wide range of effects on proteins 
and in vitro studies of denaturing individual proteins provide a better understanding of 
protein function and structure (74–77). Chemicals used to denature include strong acids 
and bases, salts, detergents, or organic solvents; examples include sodium dodecyl 
sulfate, guanidine hydrochloride, urea, hexane, and trifluoroacetic acid (74, 78). These 
chemical denaturants disrupt the interactions that stabilize the secondary, tertiary, and/or 
quaternary structures of the protein (i.e. van der Waal’s interactions, salt bridges, and 
hydrogen bonds) and alter the native state. As larger concentrations of denaturants are 
added, the protein can have meta-stable forms, as previously established in work with 
oligomeric proteins (79). One way of measuring denaturation and stable states is to use 
tryptophan fluorescence. Depending on the location of the tryptophan residues, unfolding 
will cause either quenching or increased fluorescence intensity and a melting curve for a 
protein can be used to calculate data about stability. Results here from many biochemical 





Figure 12. Chemical denaturants guanidine hydrochloride, urea, and SDS were incubated with 
CRP at various concentrations to test for pCRP to mCRP conversion. 
These incongruent effects can be attributed to differences among the denaturants 
used: GndHCl, urea, and SDS (Figure 11). SDS is a detergent that others have shown to 
denature without aggregation at high concentrations (74). However, at the low 
concentrations used in this work, it is anticipated that SDS works to stabilize the meta-
stable state of mCRP. Urea and GndHCl are chaotropic denaturants shown to have 
destabilizing effects on proteins (80, 81). Despite only having a slight structural 
difference, as seen in Figure 11, GndHCl and urea impact proteins differently. GndHCl is 
considered to be a strong chemical denaturant and was shown by others at limited small 
concentrations of GndHCl to stabilize aggregation with some proteins in the molten 
globule state, whereas urea did not (82). The strong denaturing properties and the distinct 
way that GndHCl interacts with CRP in comparison to urea can be seen in the results of 





Figure 13. pCRP to mCRP conversion with highlighted amino acid residues. CRP monomer 
contains 6 tryptophan residues (navy blue), 13 lysine residues (magenta), 14 phenylalanine 
residues (yellow), and 2 cysteine residues to form the disulfide bond (green) (83). Hydrogen 
bonding between molecules is shown in cyan (47, 48). 
One assay often used to explore the two states of CRP is gel electrophoresis. 
Whether a 2D urea gel (84), reduced SDS (59), or the conditions used here for non-
denaturing PAGE, all results show a pCRP band that runs high and a mCRP band that 
runs low. Each gel (Figure 5C, Figure 5D, and Figure 7A) shows a native pentameric 
form that stays near the stacking portion (bands in Figure 5D have been cropped). Non-
denaturing gels separate proteins based on more than molecular weight, including protein 
shape and charge. The pCRP structure has salt bridges between subunits, hydrogen 
bonding, and van der Waals forces (85). Besides these interactions for pCRP, differences 
in how pCRP and mCRP run on a gel can be attributed to a change in the pI from 6.4 to 
5.4 (67). The gel conditions include pH values of 8.3 for the running buffer, 6.8 for the 
stacking portion, and 8.8 for the running portion of the gel, supporting mCRP having 
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more charge and running farther on the non-denaturing gel. Treatment of CRP with ≥ 2.5 
M GndHCl, ≥ 3 M urea/EDTA, or 0.01% SDS with heat all run close to the molecular 
weight for a CRP monomer (23 kDa) with non-denaturing PAGE. This demonstrates a 
clear transition and separation of pCRP and mCRP bands. 
The difference in the secondary structure of pCRP and mCRP forms (Figure 9A) 
indicates that mCRP is not merely a monomeric form of pCRP, but that it undergoes a 
structural change. Types of secondary structure that show up in the 210-230 nm region 
include α-helix and anti-parallel β-sheet (86). Native CRP has two antiparallel β-sheets 
and one α-helix per protomer (Figure 13) (22, 48). CD spectra of recombinant mCRP in 
comparison to pCRP have been reported to have a significant secondary structural 
change, mainly from β-sheet to α-helix, although no spectra was published (65). This 
structural change may be what gives mCRP its different binding properties, such as C1q 
binding. Comparing mCRP treated with dilute SDS and heat while at 80 °C and then after 
being cooled shows similar spectra (Figure 9B) concluding that when mCRP is made 
with dilute SDS and heat that it does not revert to pCRP upon cooling.  
Since no intermediates were observed in the gel (only modified and native), we 
used a two-state model to fit the GndHCl Trp fluorescence data (Figure 5A, black line). 
The intermediate states of fluorescence intensity can be assumed to be a mixture of 
folded and unfolded states, not proteins that exist in an intermediate state. However, the 
work of others (49) suggests that tetramers, trimers and dimers may exist under certain 
conditions. Our work suggests that only two states exist in a purified biochemical system. 
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Other conditions and the presence of other proteins may stabilize intermediate states that 
are not observed here.  
The results of the fit are what would be expected for a multimeric protein that has 
a slow transition. The change in free energy represents the conformational stability of a 
protein and most proteins have a value of 20-60 kJ/mol for stability of the native state 
above the unfolded state (87). CRP has a ΔG°N/U of 32 ± 12 kJ/mol. In comparison, a 
ΔG°N/U for α-lactalbumin, a smaller monomeric protein, was found by others to be 10.12 
± 0.33 kJ/mol (88) and the ΔG°N/U for phenylmethanesulfonyl α-chymotrypsin, a larger 
monomeric protein, was calculated from experiments with GndHCl to be 36.4 ± 1.8 
kJ/mol (originally in kcal/mol) (69). The ΔG°N/U of pCRP to mCRP based on the 
transition with GndHCl treatment indicates that pCRP requires a substantial energetic 
input to change forms. This is consistent with the work of others in requiring large 
amounts of heat or high concentrations of urea to biochemically make mCRP (55, 59). 
GndHCl appears to transition at a similar point with both Trp fluorescence and 
non-denaturing PAGE (Figure 5A, around 2.5-3 M). The observed Trp fluorescence 
transition for urea treated CRP is gradual (from 2 – 6 M) and over a much wider range 
than that observed in the gel (Figure 5B). This gradual transition suggests that 
conformational changes are still occurring that affect the Trp environment, but that these 
changes do not broadly influence the size or charge of the protein in a way that affects 
how it runs on a gel. The transition likely occurs over a larger range of urea 
concentrations because urea is a weaker denaturant than GndHCl. Each CRP monomer 
contains 6 Trp residues, which allows for comparison to a control sample of free Trp 
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(Figure 5A and Figure 5B, open circles). The lower fluorescence for CRP treated with 4 
M GndHCl than for free Trp at the same concentration suggests quenching. Tryptophan is 
sensitive to environment and many different interactions may contribute to a decrease in 
fluorescence including aggregation or quenching from nearby residues such as 
phenylalanine and lysine (89). There are two Trp residues with an adjacent phenylalanine 
and the CRP sequence contains 13 lysine residues per monomer (Figure 13). 
Conformational changes near the tryptophan residues are most likely the cause of the 
quenching and the lower than expected fluorescence. However, aggregation of CRP may 
also explain the low Trp fluorescence followed by an increase at higher concentrations of 
GndHCl due to stabilization and protein denaturation (Figure 6A). Each denaturant has a 
slightly different change in ANS fluorescence in comparison to free ANS in solution 
(Figure 10), which points to a difference in how the denaturants change the structural 
form of CRP. Urea and dilute SDS with heat treated CRP show a larger increase in ANS 
fluorescence, with the dilute SDS form being the largest change, indicating hydrophobic 
regions being exposed. A change in the amino acid residues exposed for mCRP is 
consistent with the observance of a mCRP specific aptamer (40, 90). 
The biochemical assays for both tryptophan and ANS fluorescence indicate that 
each denaturant affects pCRP differently. In order to determine which denaturant makes a 
biologically relevant mCRP form for in vitro experiments binding to the downstream C1q 
complement protein was analyzed with an ELISA (Figure 6). Paired, two-tailed Student’s 
t-tests revealed that the only forms with statistically significant binding to C1q were 
mCRP treated with 1.5 M GndHCl and with dilute SDS and heat. Although, many 
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conditions can cause monomerization and denaturation, only certain conditions leave 
CRP in a state that is capable of binding C1q. Denaturation with GndHCl is likely harsh 
and causes full unfolding, such that the sites needed for C1q binding are no longer intact. 
Instead, the protein binds a wide variety of other proteins, like BSA, likely in a non-
specific way, similar to what others have seen with acid treated CRP (62). In previous 
research, others have shown that while CRP treatment with 5 M GndHCl appears to have 
some monomeric properties (91), various concentrations of GndHCl failed to produce a 
mCRP form with neoantigenicity (67, 91). This discrepancy was contributed to different 
pH levels for the experiments, and in light of the research here, GndHCl appears to have 
a wide variety of effects on CRP. Urea/EDTA denaturation has a similar behavior with a 
trend towards binding C1q more than BSA at high concentrations of urea. Results from a 
fluorescent anisotropy assay confirm acid treatment also did not allow CRP to retain C1q 
binding abilities (40). This agrees with recombinant mCRP and not pCRP to C1q with 
surface plasmon resonance (55). Meanwhile, gentle unfolding with dilute SDS (0.01%) 
and heat retains binding to C1q (Table 2). 
In the literature, mCRP has been made with a wide variety of methods. Treatment 
with 8 M urea-EDTA is frequently used for pCRP to mCRP conversion (32, 38, 58, 66, 
84) and our results indicate that concentrations of urea >7 M are likely to follow the 
upward trend to make a CRP form with significant C1q binding. One method commonly 
used for cellular and animal experiments is recombinant mCRP (65, 71). The 
recombinant form has been shown by others to bind C1q and is considered similar to urea 
chelated mCRP in other assays (55, 65, 92, 93). The recombinant form remains mCRP 
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and does not revert back to pCRP (65). This is good for purification, however the method 
for expression and purification is time consuming (94). The method of making mCRP 
with 0.01% SDS and heating for 1 hour at 80 °C is consistent with functional relevance 
of C1q binding, in both this work and the work of others (40). The ability to maintain 
functional relevance when the mCRP treated with heat and SDS has been diluted points 
to a permanent change in the molecular structure, which, similar to recombinant mCRP, 
indicates that mCRP is unlikely to return to pCRP. Further studies of mCRP would 
benefit from using the SDS and heat preparation method due to the consistent C1q 






Table 2. Summary of biochemical preparations of mCRP and their results. 
CRP Preparation Transition to 
mCRP 
Structural Notes C1q binding 
GndHCl Non-denaturing 






(Trp and ANS 
Fluorescence) 
Only at 1.5 M 
GndHCl 
Urea/EDTA 3 M is where an 
mCRP band starts to 




(Trp and ANS 
Fluorescence) 
Trends toward 
binding at 7M, but 
not statistically 
significant 
SDS/Heat 0.01% SDS and heat 
for 1 hour at 80 °C 




(DLS); CD spectra 
loses dip in 
secondary structure 
region 







C-reactive protein (CRP) is commonly measured as an inflammatory marker in 
patient studies for coronary heart disease, autoimmune disease, and recent acute 
infections. Because of the correlation of CRP to a vast number of disease states, CRP is a 
well-studied protein in medical literature with over 11000 references in PubMed (95). 
However, the biochemical and structural variations of CRP are not well understood. 
Conformations of CRP are thought to affect disease states differently, with a modified 
form showing neoepitopes and activating the complement immune response through C1q 
binding. Despite the broad interest in CRP, there is a noticeable gap of information in the 
biochemical literature regarding how different conformational states affect biochemical 
reactivity. In this work, we compare the unfolding of CRP using chemical denaturants 
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and identify which states of CRP bind a downstream complement immune response 
binding partner (C1q). We used guanidine HCl (GndHCl), urea/EDTA, and 0.01% SDS 
with heat to perturb the pentameric state. All treatments give rise to a monomeric state in 
non-denaturing polyacrylamide gel electrophoresis experiments, but only treatment with 
certain concentrations of denaturant or dilute SDS with heat maintains CRP function with 
downstream binding partners when measured using enzyme-linked immunosorbent 
assays. The results suggest that the final form of modified CRP and its ability to mimic 









CHAPTER THREE: CONFORMATIONAL CHANGES IN C‑REACTIVE 
PROTEIN AFFECT BINDING TO CURVED MEMBRANES IN A LIPID 
BILAYER MODEL OF THE APOPTOTIC CELL SURFACE1 
3.1 Introduction 
As established in the previous chapter, C-reactive protein (CRP) is an acute phase 
protein that is released to trigger the complement immune response with two known 
conformational states. These two states are native pentameric CRP (pCRP) and modified 
CRP (mCRP). The results from the above experiments established a protocol to make a 
biologically relevant form of mCRP. Research in this chapter applies these biochemical 
findings by making mCRP with 0.01% SDS and heating for 1 hour at 80 °C for use in 
lipid experiments. 
One main function of CRP involves binding to foreign or damaged material to 
signal degradation, allowing for removal of apoptotic cells to maintain self-tolerance. 
Native, soluble CRP (pCRP) is a homopentameric protein that binds to 
phosphatidylcholine (PC) lipids in a Ca2+-dependent manner (96). Each monomer has a 
binding site for PC (22, 48). Conversion of pCRP into a modified form results in 
exposure of neoepitopes, leading to different reactivity. Modified CRP (mCRP) then 
                                                 
1 Content for this chapter was modified from the journal article entitled “Conformational Changes in C-
Reactive Protein Affect Binding to Curved Membranes in a Lipid Bilayer Model of the Apoptotic Cell 
Surface” by Aml A. Alnaas, Carrie L. Moon, Mitchell Alton, Scott M. Reed, and Michelle K. Knowles 
published in 2017 in the Journal of Physical Chemistry B. The DOI is: 10.1021/acs.jpcb.6b11505. 
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binds downstream to binding partners, such as Factor H, C1q, and C4bp, which regulate 
the complement immune response (55). The modified form is often identified as a 
monomeric form, but multimers of CRP or other forms could also play a role in CRP 
activity (36). 
Beyond changes in molecular interactions due to conformational changes in CRP, 
conformational states have also been associated with different disease states. CRP levels 
have been linked to a wide variety of health issues, from cardiovascular disease (25, 97) 
and schizophrenia (98, 99), where high levels of CRP are related to negative outcomes, to 
autoimmune disorders, where increased CRP levels are likely protective (100–102). CRP 
is a marker of chronic inflammation (25, 48), and soluble pCRP is often measured to 
determine elevated levels that are correlated to health risks. However, it is thought that 
the modified form of CRP is the initiator of an inflammatory response in cells (30). 
Recent studies indicate that CRP plays a direct role in managing the inflammatory 
response to myocardial infarction, rather than just acting as a general marker of 
inflammation (103), with a monomeric form accumulating in plaque (104). Other recent 
work suggests that modified forms of CRP present in serum are related to obesity (60), 
and the monomeric form is also elevated in the eye during age-related macular 
degeneration (105). Despite the well-studied correlations between CRP forms and disease 
states, less is known about the molecular interactions of the different forms. 
One primary role of CRP in the body involves the recognition of damaged 
membranes, a process that depends on CRP−protein and CRP−lipid interactions. mCRP 
binds C1q, which activates the complement response (106, 107); meanwhile, binding to 
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C4bp (32) and Factor H4 attenuates the immune response. In an acidic environment, CRP 
undergoes conformational changes that expose hydrophobic portions of the protein, and 
then, CRP binds oxidized low-density lipoprotein particles, C3b, and Factor H with 
higher affinity (62). The monomeric form of CRP has also been shown to bind integrin 
proteins on the cell surface and increase inflammation (58). In almost all studies, mCRP 
has been shown to bind other proteins better than pCRP. Some of this reactivity is 
thought to be regulated via an intrinsically disordered domain, and mutations in this 
sequence dramatically affect CRP binding to downstream partners (108). 
Conformational changes in CRP clearly affect protein− protein interactions, but 
little attention has been given to how protein conformational changes affect lipid binding. 
It is interesting to note that phosphocholine is the predominant lipid head group in the 
outer leaflet of cell membranes yet CRP does not bind PC present on the surface of 
healthy cells. Beyond Ca2+, it is not clear what is needed for CRP to bind to lipid 
membranes. Past work has shown that lysophosphatidylcholine (lysoPC) (96, 109), 
oxidized lipids (50), and cholesterol are required for pCRP binding (92). LysoPC and 
oxidized PC are commonly found in damaged membranes, like those found on apoptotic 
cells, and may provide a distinguishing feature between healthy and unhealthy 
membranes (110). However, others have shown using mimics of low density lipoprotein 
particles that neither lysoPC nor oxidized PC are needed; instead, CRP can recognize PC 
when it is presented on very small (radius <15 nm) nanoparticles (38). Both lipid 
composition and the presentation of lipids on curved surfaces likely affect CRP binding. 
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To identify how CRP recognizes and binds to damaged membranes, we designed 
curved membranes containing lipids that are typically present on the cell surface (PC, 
lysoPC) using a nanoparticle patterned surface with a fluid, supported lipid bilayer 
deposited on top. Lipid fluidity was measured using fluorescence recovery after 
photobleaching (FRAP) methods. Using quantitative fluorescence microscopy, we 
observed that the shape of the membrane alters CRP binding, with positively curved 
membranes recruiting more CRP than flat membranes. However, curvature-dependent, 
lipid binding depends greatly on the conformation of CRP. mCRP prefers curvature 
(radius of curvature, ROC = 27−55 nm), but the soluble pentameric CRP does not bind 
more than the CRP antibodies alone. Addition of lysoPC increases the accumulation of 
CRP to both flat and curved membranes, recruiting mCRP and pCRP to curved 
membranes more than bilayers containing only phosphatidylcholine. Interestingly, the 
highly curved membranes (ROC = 27 nm) bind mCRP to a lesser extent when compared 
to lower curvatures (ROC = 55 nm). Overall, the mechanism by which CRP recognizes 
membranes depends on the conformation, lipid composition, and shape of the membrane. 
3.2 Method 
Experimental Contributions 
The majority of the research in this chapter was performed by Dr. Aml Alnaas. 
Mitchell Alton and Dr. Michelle Knowles contributed to image analysis coding and the 
processing of the images. Carrie Moon executed the dynamic light scattering experiment 




CRP was purchased from Academy Bio-Medical Company (Houston, TX) and 
stored at 4 °C. Monomeric CRP was made from CRP by adding 0.01% SDS and heating 
at 80 °C for 1 h in buffer, as previously described (40). Soy L-α-lysoPC (lysoPC) and 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) were purchased from Avanti 
Polar Lipids (Alabaster, AL). Streptavidin labeled with Alexa 488, N-((6- 
(biotinoyl)amino)hexanoyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine 
(Biotin-X-DHPE), red fluorescent (580/605) carboxylate modified fluospheres (d = 40 
and 100 nm), Marina Blue 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (MB-
DHPE), and secondary goat anti-mouse immunoglobulin G with Alexa 488 were 
purchased from Thermo Fisher Scientific. Primary anti-C-reactive protein (C6 and D7 
mouse monoclonal antibodies) and mouse IgG monoclonal antibody were purchased 
from Santa Cruz Biotechnology. Buffers used were PIPES buffer (2 mM CaCl2, 30 mM 
PIPES, 140 mM NaCl, pH 6.4) or HEPES buffer (30 mM HEPES, 140 mM NaCl, 2 mM 
CaCl2, pH 6.5). All remaining chemicals were purchased from Sigma-Aldrich. 
Dynamic Light Scattering 
To determine that CRP was not self-aggregating in storage, dynamic light 
scattering (DLS) was performed on a DynaPro Plate Reader II with Dynamics version 7 
DLS software with a 384 well glass-bottom plate (Greiner Bio-One Sensoplate #781892). 
CRP was diluted to 500 μg/mL in PIPES buffer, and 50 μL each was placed into four 
wells for measurements. The plate was centrifuged at 200 rpm for 2 min. Settings for 
measurements were a 5 s acquisition time with autoattenuation at 25 °C. The solvent 
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setting for the system used was based on phosphate-buffered saline with a refractive 
index of 1.333 (at 589 nm for 20 °C) and a viscosity of 1.019 cP. Results are from three 
experimental days, where each measurement was in quadruplicate wells. The software 
used a Rayleigh Spheres model to fit the data, giving results for the hydrodynamic radius, 
% mass, and molecular weight (Figure 14). 
 
Figure 14. Dynamic light scattering of pCRP shows no aggregates. One example of a histogram 
of radii measured for pCRP is shown and representative of 12 measurements. 100% of the mass 
was less than 10 nm radius in all 12 samples measured. The average of 12 measurements was 4.4 
+/- 0.3 nm radius and 110 +/-20 kDa for molecular weight. The error listed is the standard 
deviation. 
Supported Lipid Bilayers 
Supported lipid bilayers were made following previous methods (8). Briefly, the 
supported lipid bilayer was formed over fluorescent polystyrene nanoparticles (44 or 100 
nm diameter Fluospheres from Life Technologies) deposited upon a flat glass surface (8 
well plate from Lab-Tek Chambered Borosilicate Coverglass System, Thermo Fisher) at 
a density of 0.01−0.05 nanoparticles/μm2. Liposomes were prepared by probe sonicating 
lipid films (0.125 mM lipids in PIPES buffer), and lipid bilayers were created by adding 
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100 μL of the sonicated lipid solution to each well followed by incubation at 37 °C for 1 
h. CRP (50 μg/mL) was incubated with the lipid bilayer at 37 °C for 2 h. Membrane 
fluidity was tested with FRAP using MB-DHPE, as described in previous work (8), and 
confocal microscopy was performed to measure colocalization between nanoparticles and 
the protein. For labeling of CRP, the primary and secondary antibodies were preincubated 
together in 1:1000 ratios for 30 min at room temperature. Preincubated antibody solution 
(100 μL) was added to each well for a total volume of 200 μL. Two different primary 
antibodies were tested (D7 and C6). 
Lipid films consisted of POPC, lysoPC, and MB-DHPE. The ratio of lipids 
included 0−3% lysoPC and 2% MB-DHPE, and the remainder was POPC. Specific ratios 
are stated in the text. For Biotin-X-DHPE samples, the ratio was POPC 99% and Biotin-
X-DHPE 1%. Alexa488-labeled Streptavidin was added at a final concentration of 25 
μg/mL. 
Confocal Microscopy 
A point-scanning confocal microscope (Olympus Fluoview) was used for FRAP 
experiments and for two-color imaging of red fluorescent nanoparticles and green 
fluorescent antibodies. For two-color imaging, the red and green fluorescence were taken 
sequentially to reduce bleedthrough with a 100× objective such that one pixel was equal 
to 124 nm. The red channel was excited with a 559 nm laser with an emission window of 
575−675 nm. The green channel was excited with the 488 nm line of an argon ion laser 
with an emission window of 500−545 nm. When FRAP was performed, a 405 nm laser 
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was used to excite and photobleach MB-DHPE, and emission was detected from 425 to 
475 nm.  
 
Figure 15. Supported lipid bilayers were created on a surface containing red fluorescent 
nanoparticles and then imaged after incubation with CRP. (A) Red fluorescent nanoparticle 
images mark sites of curvature. (B) Green fluorescently labeled protein (pCRP) is imaged 
separately. Red positions are located using a spot-finding algorithm and then cropped. Several 
positions are shown with circles. The same locations are cropped from the green image, shown in 
yellow circles, yielding pairs of images. (C) Three pairs of cropped images (3.1 μm wide). Panels 
r1−3 were cropped from A positions 1−3, and g1−3 were cropped from B. (D) The Pearson 
correlation coefficient is calculated for image pairs, and a histogram of all coefficients is plotted 
for pCRP at regions of curvature (black) and at random positions (magenta line). (E) A radial 
plot of the cropped images is calculated by averaging the normalized intensity of all pixels that 
are a certain distance from the center pixel, where a nanoparticle is located. Error bars are the 
SEM. 
Image Analysis 
Images were analyzed in MATLAB using location-guided colocalization 
methods, and the analysis is summarized in Figure 15. To find locations of curvature 
marked by red fluorescent nanoparticles, spot-finding methods were used based on 
freeware (111) that is designed from the methods of Crocker and Grier (112). Only the 
spot-finding portion of the code was used for this work. Locations were excluded if they 
were within 9 pixels of another location or within 12 pixels of the image edge. After 
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locations were identified, images were cropped from both red and green channels, 
yielding pairs of images. From the pairs of images, we measured first the distribution of 
Pearson’s correlation coefficients and second the average radial plot of the green cropped 
images. This was done by averaging all pixels that are a specific distance from the center 
pixel. For example, there are four pixels that reside one pixel (124 nm) away from the 
center, and these are averaged to give the second data point. Four pixels that reside 175 
nm from the center are averaged to give the third data point and so on. MATLAB code 
for the radial averaging function is available upon request. The intensity was normalized 
for each radial plot by dividing by an average radial plot of Alexa488 Streptavidin bound 
to Biotin-X-DHPE (SB-DHPE), which acts as a measure of the membrane surface area. 
The normalized intensity is termed ICRP/ISB‑DHPE. After normalizing to SB-DHPE, the 
peak height (amount bound to curved regions), offset (amount bound to flat regions), and 
sorting ratio, Ipeak/Ioffset, were calculated for samples where binding to the flat areas was 
observable above the background (113). The offset was calculated by averaging all 
values in the radial plot greater than 0.75 μm away from the center. All error bars are the 
standard error of the mean (SEM). 
The correlation function calculation was obtained from Dr. Justin Taraska (114). 
All other plots and significance testing were performed in GraphPad Prism (La Jolla, CA, 
U.S.A.).  
3.3 Results 
To determine whether or not CRP preferentially bound to curved membranes, 
supported lipid bilayers were created over a nanopatterned surface. Fluorescent 
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nanoparticles were deposited at a density of 0.01−0.05 nanoparticles/μm2 onto a cleaned 
glass surface. Then a bilayer was created on top using liposome deposition methods. CRP 
was incubated with the curved membrane surface and labeled with green fluorescent 
antibodies. Two-color, confocal imaging was performed to determine whether or not 
CRP bound to curved membranes. The red fluorescent nanoparticles mark locations of 
membrane curvature, as demonstrated in previous work (8). The green fluorescent 
channel relates the amount and location of CRP. The sample shown in Figure  contains 
CRP from human serum, the soluble, pentameric form commonly detected in medical 
diagnostics for inflammation. The lipid bilayer is composed of MB-DHPE (2%) and 
POPC (98%), a common lipid on the cell surface, with regions of curvature that have a 
radius of curvature (ROC) of 55 nm.  
To quantify imaging data, nanoparticles were identified using a spot-finding 
algorithm (112). Nanoparticles that were separated by more than 9 pixels from other 
nanoparticles and more than 12 pixels from the edge of the images were selected and 
cropped to 3.1 μm × 3.1 μm (25 × 25 pixel) images (Figure 15A). The same locations 
were cropped from the CRP channel (Figure 15B), and three examples of single cropped 
images are shown (Figure 15C). In CRP images, the intensity is variable with hazy 
fluorescence shown in g1, the background level of fluorescence in g2, and a fluorescent 
spot near a nanoparticle position in g3, whereas there is always a clear spot for the 
nanoparticle in images r1−3. Because nanoparticles are very bright relative to the 
background and monodisperse in both size and intensity, it is straightforward to automate 
the identification of curved membrane locations. The identification of regions of 
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curvature first allows us to automate our analysis using location-guided colocalization 
methods (8, 114, 115). This method of data analysis yields pairs of images, like those in 
Figure C, which can be further analyzed to obtain distribution information or averaged to 
obtain bulk information. 
From individual pairs of images, the Pearson correlation function was calculated 
to relate how similar the two images are, with −1 being images that are opposites and +1 
being those that are identical. The distribution of correlation values is plotted as a 
histogram, and very little is observed to be correlated in samples containing pCRP and 
curved POPC bilayers (Figure D, black bars). Random positions have a similar 
distribution (Figure D, magenta curve). The correlation function is useful for 
colocalization measurements, but the intensity information is lost; therefore, we 
performed another measurement that retains information related to the amount of protein 
present at nanoparticle regions. From the individual cropped, green (CRP) images (n = 
3297), a radial plot of the normalized intensity as a function of the distance from the 
center pixel was calculated (Figure E). This was done by averaging all pixels that are the 
same distance from the center, as described in the methods. After subtracting the 
background intensity, the intensity of samples lacking green fluorophores, data were 
normalized by dividing by the radial plot of SB-DHPE, which acts as a general 
membrane marker (Figure 16). In the radial plot, there are two pieces of information: the 
peak height (distance = 0 μm) and the offset (distance > 0.75 μm). The height is a 
measure of the amount of fluorescence at regions of curvature, and the offset is a measure 
of the fluorescence due to binding to flat membranes. These methods of analysis are used 
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to quantify how the lipid composition, protein conformation, and membrane shape 
separately affect CRP recognition of membranes. 
 
Figure 16. Radial plots used to calculate surface area normalized radial plots. A) The raw 
intensity measurement of mCRP (black dots) and pCRP (open circles) at regions of curvature 
with radii of 55 nm. B) The raw intensity measurement of Alexa488 labeled Streptavidin attached 
to Biotin-X-DHPE at 55 nm (black circles) and 29 nm (open circles). The background intensity of 
samples containing no green probes was subtracted from both A and B. C) Strep-Biotin-X-DHPE 
(SB-DHPE) at 55 nm (black circles) and 27 nm (open circles) was normalized by dividing by the 
average intensity for all pixels at a distance 0.75 of greater from the region of curvature. To 
calculate Figures in the text that contain normalized data, ICRP/ISB-DHPE, plots like those in A are 
divided by those in C based on the ROC. 
CRP Conformation Affects Binding to Curved Membranes 
The conformation of CRP affects binding to downstream proteinaceous partners, 
such as C1q and Factor H (25). Here we tested whether CRP conformation affects lipid 
binding to both curved and flat regions of the membrane. Supported lipid bilayers 
containing 98% POPC and 2% MB-DHPE were formed over top of a fluorescent 
nanoparticle patterned surface (ROC = 55 nm) and then incubated with CRP and CRP 
antibodies. The monomeric form of CRP (mCRP) was made as previously described (40). 
In this preparation, the tertiary structure remains intact, as demonstrated by the ability of 
mCRP to bind downstream partners of the complement immune response in a way that 
acid-treated or fully denatured CRP does not (40). Visually, mCRP shows high 
colocalization to nanoparticle sites and is also present in flat regions when compared to 
pCRP (Figure 17A). The average of the cropped, nanoparticle images shows a spot in the 
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center, as expected. All images, except the red fluorescent nanoparticle image, are scaled 
identically and linearly for direct comparison. A spot appears in the center for mCRP, 
pCRP, and samples with no CRP (containing only antibodies, termed “none”) but not for 
samples where the surface has been blocked with bovine serum albumin (BSA) instead of 








Figure 17. Monomeric CRP and pCRP were incubated on curved supported lipid bilayers and 
then imaged using confocal microscopy. (A) Average images of nanoparticles, mCRP, pCRP, 
samples with antibodies only (“none”), and BSA-blocked samples with antibodies and no CRP 
(“BSA”) have been cropped from regions selected from nanoparticle positions. Random positions 
were also selected and cropped. The images are all scaled linearly and identically. (B) The 
distribution of correlation coefficients for pairs of cropped images is measured for mCRP (black) 
and randomly selected positions in a pCRP sample (gray dashed line). (C) The average of the 
distribution is plotted for mCRP, pCRP, images with antibodies alone, and CRP at random 
regions instead of curved membrane regions. (D) From the images, the intensity is averaged 
radially and normalized to show the accumulation of mCRP (black circles) and pCRP (open 
circles). (E) The height and the offset are plotted for each radial plot. In all bar graphs, the error 




To assess the interaction between CRP conformers and curved membranes 
further, correlation coefficients were calculated from pairs of cropped images (Figure 
17B). mCRP (black bars) and pCRP (Figure 15D) are clearly different; mCRP has a 
higher correlation to the nanoparticle positions, suggesting higher preference for 
curvature. The average correlation coefficient is 0.29 for mCRP (Figure 17C), and this is 
due to a large diverse distribution (Figure 17B). pCRP has an average of 0.03, which is 
similar to samples where no CRP has been deposited. Randomly chosen positions show 
near-zero correlation. 
Monomeric CRP accumulates at a curvature, and the amount of fluorescence at 
nanoparticle positions is quantified from the average radial distribution of the cropped 
images (Figure 17D). The normalized radial average shows that mCRP binds both flat 
regions, as observed by the offset, and nanoparticle regions, observed by the peak height, 
better than pCRP. pCRP has no measurable signal above background for flat regions and 
is similar in intensity to antibodies alone at regions of curvature, suggesting that pCRP 
does not bind membranes well. The increase in fluorescence at curvature relative to the 
background is shown as a bar graph of the peak height and offset intensity for mCRP, 
pCRP, and no CRP present (Figure 17E). The height is the first point in the radial curve. 
The offset is measured from the average for all distances from 0.75 to 3.1 μm away from 
the center, a distance greater than the spread of the intensity in the center but less than the 
nearest-neighbor distance. In Figure 17E, the average peak height and offset of all 
cropped images are plotted, and both are higher for mCRP relative to those for pCRP. 
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Lysophosphatidylcholine Increases CRP Binding to Membranes 
The presence of lysoPC has long been known to enhance CRP binding to the 
surfaces of artificial bilayers (96). To investigate how changes in the chemical 
composition affect CRP binding, supported lipid bilayers that contained 3% lysoPC, 2% 
MB-DHPE (to measure fluidity), and 95% POPC were created over a nanopatterned 
surface where both flat and curved membrane regions were measured simultaneously. 
The presence of lysoPC increased the Pearson correlation coefficient for both pCRP and 
mCRP (Figure 18A, B). In both cases, there was an increase in the distribution at larger 
coefficients. In Figure 18C, the average correlation coefficient is shown relative to 
random positions, and a dashed line indicates the position without lysoPC (shown in 
Figure 15D and Figure 17B). There is an increase by approximately 0.1 for both forms of 






Figure 18. CRP was incubated with lysoPC containing membranes (LysoPC: POPC: MB-DHPE 
at a 3:95:2 molar ratio) that had regions of curvature (ROC = 55 nm). From cropped images, the 
Pearson correlation coefficient was calculated for (A) pCRP (black bars) and (B) mCRP (black 
bars). The gray dashed line in both plots denotes the distribution of the correlation coefficient of 
protein to regions of curvature in randomly selected positions in pCRP samples. (C) The average 
value of the correlation function distribution is shown with the SEM for both nanoparticle and 
random positions. The dashed line shows the average value when lysoPC is not in the membrane 
and nanoparticle positions are selected. (D) Normalized radial averages of mCRP and pCRP 
binding to sites of curvature. mCRP and pCRP binding to lysoPC bilayers (black circles and 
white circles, respectively), mCRP (black dashed line), and pCRP (gray dashed line) on bilayers 
without lysoPC. (E) The peak height and offset are plotted side by side for mCRP, pCRP, and no 
CRP. (F) The difference between the height and offset, ΔIntensity, for mCRP (solid) and pCRP 
(striped) with and without lysoPC. 
To determine how much CRP accumulates at nanoparticle regions when lysoPC is 
present, the intensity of CRP fluorescence was quantified (Figure 18D−F). The height of 
the radial plot of mCRP increases only slightly, as shown in Figure 18D, where the black 
dashed line is the radial plot without lysoPC and the black circles are that with lysoPC. 
The height of the radial plot of pCRP at nanoparticles increases approximately 4-fold, as 
shown in Figure 18D, E, where the gray line is the radial plot of pCRP without lysoPC 
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and the open circles depict the radial plot in the presence of lysoPC. The difference in 
normalized intensity between flat and curved regions, ΔIntensity (Figure 18F), is 
significantly higher (p < 0.05) for both mCRP and pCRP, indicating that lysoPC serves to 
increase binding of all forms of CRP to curved regions more so than that to flat regions 






Figure 19. CRP was incubated with supported lipid bilayers with a smaller nanoparticle support 
(d = 44 nm, ROC = 27 nm) and imaged using confocal microscopy. Lipid bilayers contained 98% 
POPC and 2% MB-DHPE. (A) Pearson correlation coefficient distribution for pCRP and 
nanoparticle images (N = 1574), on samples containing a ROC = 27 nm. (black). (B) Pearson 
correlation coefficient distribution for mCRP and nanoparticle images (N = 1368) on samples 
containing a ROC = 27 nm (black). The gray dashed curves in both (A) and (B) are from 
randomly selected positions in a pCRP sample. (C) Average of the correlation coefficient as a 
function of curvature. (D) The peak height (normalized intensity at d = 0 μm) and offset 
(normalized intensity at d = 0.75−3.1 μm) for mCRP at 27 and 55 nm were measured from the 
normalized radial plot. Error bars are the SEM. 
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Membrane Shape Affects CRP Binding 
The shape of a membrane has been shown to affect protein binding for a variety 
of membrane-associated proteins, such as BAR domains (116), amphipathic helices (16, 
117), and lipid-anchored proteins (118, 119). By decreasing the size of nanoparticles used 
as a template for the supported lipid bilayer, higher curvatures (ROC = 27 nm) were 
examined. The Pearson correlation coefficient distribution (Figure 19A, B) was affected 
by membrane shape for both conformations. The distribution shifted to slightly higher, 
more colocalized coefficients for pCRP (Figure 19A), whereas the shift was to lower 
coefficients for mCRP (Figure 19B). The average correlation coefficients for both mCRP 
and pCRP are shown (Figure 19C), and a statistical difference in colocalization is 
observed for both conformations. However, the change in pCRP accumulation is small, 
with pCRP slightly favoring higher curvatures relative to the large change in mCRP 
accumulation, where mCRP favors lower curvatures. The results were similar when 3% 
lysoPC was included in the bilayer (Figure 20). 
 
Figure 20. CRP recruitment to curvature with a smaller nanoparticle support (d = 44 nm, ROC = 
27 nm) was measured using confocal microscopy. Lipid bilayers contained 95% POPC, 3% 
LysoPC, 2% MB-DHPE A) The Pearson’s correlation coefficient distribution for mCRP and 
nanoparticle images at a ROC of 25 nm (black bars). B) The Pearson’s correlation coefficient 
distribution for pCRP and nanoparticle images at a ROC of 25 nm (black bars). In both plots, the 
gray curve is the distribution of correlation values for randomly selected positions. 
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The accumulation of mCRP at regions of curvature was quantified by comparing 
the binding of mCRP to flat regions (offset) to the binding of mCRP to regions of 
curvature (peak height) after normalizing the radial plots with SB-DHPE (Figure 
19D,Table 3). The sorting coefficient was calculated by dividing the normalized peak 
intensity by the intensity measured in the offset, and these coefficients are summarized in 
Table 4. Sorting coefficients were not calculated for pCRP because the binding of pCRP 
to flat regions was close to 0 after background subtraction and not greater than the 
binding of free antibody to flat membranes. 
 
Table 3. Summary of mCRP and pCRP Accumulation at Curved and Flat Regions a  
 Iflat Ipeak @ ROC 55 
nm  
Ipeak @ ROC 27 
nm 
mCRP  108 ± 3  844 ± 17  119 ± 4 
pCRP  4 ±2  59 ±6  56 ± 2 
mCRPlyso  65 ± 3  893 ± 17  n/a 
pCRPlyso  29 ± 2  289 ± 11  n/a 
aThe intensity was normalized by dividing by the intensity of SBDHPE, as described in 
Figure . 
 
Both the increase in intensity at the peak relative to the flat regions and the 
average correlation coefficient convey that mCRP collects at larger nanoparticles (lower 
curvature) at a density greater than the accumulation at smaller nanoparticles (higher 
curvature). However, pCRP binds membranes minimally, unless lysoPC is present, in 
agreement with the work of others (96, 120). The shape of a membrane clearly affects 
CRP binding, and this depends on the form of CRP. The mechanism by which mCRP and 





Table 4. Sorting Coefficients for mCRP a 
 ROC 55 nm  ROC 27 nm 
mCRP 7.8 1.1 
mCRPlyso 13.7 n/a 
aSorting coefficients, Ipeak/Ioffset, are determined by dividing the normalized peak 
intensity by the normalized flat intensity. 
 
3.4 Discussion 
The physiological activity of CRP depends on its ability to bind membranes and 
trigger an immune response. Others have demonstrated that the conformational state of 
CRP affects protein binding (24, 32, 58) and the subsequent regulation of an 
inflammatory response by the complement cascade (107), but little is known about how 
lipid interactions are affected by alterations in CRP conformation. In our work, we 
measured CRP accumulation on membranes, focusing on a commonly prepared 
monomeric form and the native, pentameric form. The ability of the different forms to 
bind membranes of varying shapes and lipid composition was examined using a 
nanoparticle- based assay that allows for separate adjustment of the shape and chemical 
composition. The following conclusions can be drawn from the data to further 
characterize the mechanism by which CRP identifies damaged membranes in the body. 
Conformation of CRP Affects Binding to Curvature. The modified form of CRP 
binds lower curvatures (ROC = 55 nm) more effectively than pCRP (Figure 15 and 
Figure 17). We hypothesize that the mechanism by which mCRP binds curvature better 
than pCRP is driven primarily by hydrophobic regions of CRP being exposed once the 
pentamer begins to dissociate (36, 92, 121). The faces that connect the protomers in the 
pentameric form are enriched in hydrophobic amino acids that preferentially insert into 
membranes or aggregate. Other proteins, such as amphipathic helices, preferentially 
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insert into curved membranes through hydrophobic interactions with the defect sites that 
form as a lipid membrane bends around a curved surface (118). These defect sites are 
thought to allow exposure of the hydrophobic tails to the surrounding aqueous solution 
and potentially interact with hydrophobic proteins. However, defect site binding to 
membranes alone cannot explain the clear preference that mCRP has for lower curvatures 
over higher curvatures and flat membranes (Figure 19, Table 4). The current model of 
defect site binding suggests that more defect sites exist as a membrane bends with higher 
curvature. Therefore, defect site binding proteins, like lipid-anchored proteins and 
amphipathic helices, bind higher curvatures better than lower curvatures (16, 118, 119). 
Defect site-based curvature sensing predicts a linear dependence of the sorting ratio 
(Ipeak/Ioffset) on 1/ROC (122). This trend differs from the curvature preference of mCRP 
binding, where mCRP prefers moderate curvature over high or flat regions. The driving 
force in defect site binding is the reduction in free energy of the system unless other 
mechanisms (described below) are acting on the system to create an optimal curvature for 
protein binding. 
One mechanism by which a specific or optimal shape preference comes about is 
from a 3D protein structure that has an intrinsic curvature, like a BAR domain (116) or a 
clathrin coated pit (123). These larger structures act as a driving force for sorting of the 
protein at sites of curvature. These structures then prefer lipid membranes that match in 
shape to their intrinsic curvature. mCRP could form larger oligomers on membranes that 
give rise to structures with a specific curvature preference. It is possible that higher-order 
structures are what drive CRP binding and these structures form better on membranes 
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with a radius of curvature of 55 nm as opposed to 27 nm. A second mechanism by which 
specific shapes of membranes could be sensed involves molecular crowding. For 
example, the protein CALM, a clathrin adapter protein, has a preference for binding 90 
nm diameter liposomes (124). CALM shows this preference by using an amphipathic 
helix to insert into defect sites, and CALM itself is not thought to form higher-ordered 
structures. Instead, the packing into defect sites is limited by molecular crowding of the 
rest of the protein as it binds only on one leaflet. In the same way, mCRP could insert 
hydrophobic portions into defect sites but be limited from fitting more due to crowding. 
We see no direct evidence of higher-ordered structures in our assay, but curvature sensing 
of a specific size could arise from a multimeric mechanism or a mechanism by which 
molecular crowding limits the protein density at higher curvatures. 
An alternative interpretation for the observation of specific curvature sensing in 
the data could arise from the conformational state of the protein being different when 
bound to 55 nm curved sites than higher curvature membranes. It is possible that the 
conformational state of CRP exposes neo-epitopes when bound to 55 nm curved 
membranes and these neoepitopes have a higher affinity to antibodies. It is well-known 
that different CRP conformers bind differentially to CRP antibodies (125, 126) and CRP 
conformation is affected when directly labeled (59). If the observed accumulation at 
curvature is an effect of protein state, this would be physiologically relevant to the 
inflammation field, where the state of CRP at sites of inflammation, like plaque, is 
unclear. Changes in conformational state would likely affect downstream binding in the 
complement cascade and with cell surface receptors, as others have shown when 
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comparing mCRP and pCRP (24, 127). Further studies of CRP reactivity to C1q, C4bp, 
and Factor H while on a wide range of curved membranes could elucidate whether these 
CRP clusters have unique physiological relevance and what the optimal curvature is for 
CRP clustering and/or neoepitope exposure. 
In sharp contrast to mCRP, we see a lack of pCRP binding to curvatures 
containing only POPC (Figure 15 and Figure 17). This agrees with the fact that pCRP 
does not bind healthy cells and does not accumulate well on PC containing liposomes 
(96, 104, 120). However, once the membrane curvature was increased (ROC = 27 nm), 
pCRP exhibited a slightly higher accumulation at curved membranes regions (Figure 
19A−C). This is in agreement with past work on CRP (38) where very high curvatures 
(ROC = 10−15 nm) were tested and shown to bind pCRP better than lower curvatures 
(ROC = 20−35 nm). However, in this past work, the lower curvatures likely bound pCRP 
to a lesser extent, below the detection level for the binding assay used, based on the fact 
that CRP was activated in some way to be able to bind C1q after incubation with curved 
membranes (38). All binding was Ca2+-dependent, indicating that the pCRP/PC 
interaction was likely through binding of the PC moiety as opposed to an interaction with 
the lipid tails. Although we observe a small increase in pCRP colocalization at membrane 
locations with a ROC of 27 nm relative to 55 nm, it is likely that pCRP binds better to 
higher curvatures than those measured here, like others have shown. 
Lipid Composition Affects Binding to Membranes 
The membrane association of pCRP is also enhanced by changes in the lipid 
composition. Once lysoPC is added to the lipid bilayer, pCRP binds at a higher density to 
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curved regions (Figure 18). This is consistent with the fact that CRP does not bind 
healthy cells that contain lipids similar to POPC. Damaged membranes often contain 
modified lipids, and modifications that convert PC to lysoPC on the cell surface are 
required for recruiting CRP to cells or particles that need clearance (96, 120). In our 
work, lysoPC enhances binding more at curved regions than on flat regions, as shown by 
the increase in height of the radial plots in Figure 18D−F. This could be due to the 
accumulation of single-tailed lipids, like lysoPC, at sites of curvature (8); there is a higher 
density of lysoPC at the curved regions to associate with CRP. Others have suggested 
that lysoPC introduces irregularities into artificial lipid bilayers (96) and that these 
features are essential to binding pCRP. 
The presence of lysoPC affects pCRP more than mCRP, increasing the 
accumulation by 4-fold as opposed to a 10% increase at curved membranes (Figure 18F). 
This suggests that mCRP associates in a way that does not depend on binding lysoPC, 
whereas pCRP association does. pCRP likely interacts through head group interactions 
within the Ca2+-dependent PC binding site, as others have observed on highly curved 
membranes lacking lysoPC (38). However, the mechanism by which pCRP binds 
membranes may be different when lysoPC is present. Recent work suggests that pCRP 
has a non-Ca2+-dependent, lysoPC binding site, on the side opposite the PC binding site 
(109). This site could be lost upon monomerization, leaving mCRP to interact with 




In summary, we utilized a nanopatterned substrate to introduce curvature into 
continuous lipid bilayers for quantitative image analysis of CRP−lipid interactions. One 
major advantage of this assay is the ability to separately tune chemical composition and 
membrane shape (8). This work demonstrates that the conformational state of CRP 
affects lipid binding. Monomeric CRP readily associates with membranes, favoring sites 
of curvature over flat regions. Native pCRP does not easily associate with membranes 
until the curvature is high, likely higher than that tested here, or until lysoPC is 
introduced. CRP likely recognizes damaged lipidic materials through a mechanism that 
combines PC head group binding by pCRP and membrane insertion into defect sites, 
which stabilizes the conformational conversion to mCRP. Both of these types of 
interactions are potentially strengthened at sites of curvature and could aid in CRP’s role 









CHAPTER FOUR: NOVEL MODIFICATIONS TO A NANOPARTICLE 
PATTERNED SUBSTRATE ASSAY 
4.1 Introduction 
Experiments studying binding of CRP to curved membranes show the ability of 
the nanoparticle patterned substrate assay outlined above to be applied to studying a 
system where peripheral membrane proteins bind to a membrane. Other systems where 
membrane curvature may play a role in protein binding include BAR domains and 
membrane trafficking (16, 124, 128). The method for a membrane curvature assay 
published by our lab involves first depositing nanoparticles for a patterned substrate 
followed by a deposition of liposomes to form a supported lipid bilayer (8). Others have 
shown the advantages of using colloidal lithography to deposit nanoparticles, which can 
be followed by a layer of silicon dioxide through sputter coating (129). This chapter 
focuses on experiments that combine these two methods to allow for the reuse of the 
patterned substrate as well as the ability to use it with cellular experiments. 
A challenge with sputter coating is that a flat coverglass must be used. The 
addition of fabricated silicone or 3D printed chambers to the coverglass system allows for 
less volume. 3D printing is becoming more accessible, as seen by the dedicated website 
of the NIH 3D Print Exchange (https://3dprint.nih.gov/). There are currently no 3D 
printing files for chambers available, so the chambers designed here will be a valuable 
addition and option for scientists. 
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In addition to being a patterned substrate, the use of fluorescent nanoparticles has 
the added functionality to be able to be used for colocalization analysis beyond simply 
inducing curvature. Inducing curvature into cells is a new concept and could be useful for 
studying processes like endocytosis and exocytosis to see if certain proteins sort to sites 
of curvature. By sputter coating a thin layer of silicon dioxide on top, the nanopatterned 
substrate is not only reusable, but also works with many assays, such as atomic force 
microscopy (AFM) and colocalization analysis using supported lipid bilayers and a 
fluorescent probe. In depth colocalization analysis of different lipid bilayer compositions 
are shown here. 
4.2 Method 
Experimental Contributions 
Alan Weisgerber did the deposition and melting of most of the nanoparticle 
patterned coverglass used here. Dr. Xin Fan (University of Denver, Physics and 
Astronomy) performed the sputter coating. Dr. Michelle Knowles and Mitchell Alton 
contributed the majority of the MATLAB code. All other experiments and data analysis 
were completed by Carrie Moon. 
Materials 
Attofluor cell chambers (Invitrogen A-7816) are stainless steel, autoclavable 
holders for 25 mm round coverglass. These were used for deposition of 0.1 µm 
fluorescent polystyrene nanoparticles (Thermo Fisher fluospheres) for cellular and 
supported lipid bilayer imaging experiments. Yellow-green fluospheres (Thermo Fisher 
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F8803) were used for AFM experiments and red fluospheres (Thermo Fisher F8801) 
were used in the other experiments performed here. 
Silicone Rubber Chambers 
Silicone rubber baking mats were cut into a shape with four chambers to fit on top 
of a coverglass inside the Attofluor chamber. The overall shape was designed to have 
four circular chambers with a small triangular notch near the top (for orientation when 
imaging). Silicone rubber was cut using an electronic die cutting machine (Cricut 
Personal/V1). Superglue was used to adhere the silicone rubber to the glass with a semi-
permanent bond. Experimental working volume was 20 µL per well with an overall total 
volume of 30 µL maximum for a droplet shape. This allows for washing off liposomes 
with the addition and removal of 5 µL. Due to the small volumes, some evaporation 
occurred during lipid incubation and extra buffer was added (5 µL) as needed. 
 
Figure 21. Chambered holders designed for different well volumes. A) Silicone rubber miniature 




3D Printed Chambers 
A chambered structure with walls was designed in Autodesk Fusion 360 software 
to have 4 pie shaped wells. Wells were designed to fit on top of a coverglass after it has 
been inserted into an Attofluor holder. 3D prints were made using a Prntrbot Plus (Model 
1504) with 1.75 mm polyethylene terephthalate (PETG) filament (Maker Geeks HD 
Black Glass). PETG plastic was chosen over acrylonitrile butadiene styrene (ABS) or 
polylactic acid (PLA) filament due to strength, low odor, and environmentally friendly 
properties. Prints were done using Ultimaker Cura 15.04 software 
(https://ultimaker.com/en/products/cura-software) with settings of 50% fill density, 
0.1984 mm layer height, 0.8 mm shell thickness, 40 mm/s speed. The printing 
temperature was optimized to 240 °C. 3D prints were glued on with silicone elastomer 
epoxy (Sylgard 184, used at a 10:1 ratio) or superglue for a semi-permanent bond or with 
Gorilla brand epoxy for a permanent bond. Once 3D print was placed, the epoxy or glue 
was allowed to set at appropriate curing times and temperatures (10-20 minutes at room 
temperature or 1 hour at 80 °C). The prints with coverslips attached were handled with 
tweezers and the underside was inspected for areas that did not seal. Fresh epoxy or glue 
was pushed under in those areas with a toothpick and allowed to cure again. Total 
maximum volume in each well is 100 µL, with a working volume of 75 µL, allowing for 
the addition of 25 µL for a liposome wash. 
Nanoparticle Patterned Coverglass 
In the Attofluor chamber, nanoparticles were deposited on a cleaned 25 mm round 
coverglass using previously established protocols and concentrations (see Appendix A) 
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(8). Nanoparticles were allowed to incubate for 15 minutes at room temperature before 
being placed in a 100 °C oven for 10 minutes. After heating, the coverglass is rinsed 5 
times with deionized water. 
 
Figure 22. Illustration of modification to nanopatterned substrate for curvature assays. 
Fluorescent nanoparticles (radius 50 nm) have been used previously to induce curvature with 
supported lipid bilayers. The method outlined here has the addition of heating to melt the 
nanoparticles slightly and of a 30 nm silicon dioxide coating. Figure not drawn to scale. Lipid 
bilayers are approximately 4 nm. 
Nanoparticle patterned coverglass was attached to sputter coat stage with Kapton 
tape. A Phase II J sputter coater (AJA International, Inc.) was used to deposit 30 nm of 
silicon dioxide (Figure 22, 2300 s at 0.13 Å/s deposition rate). Some coverglass had the 
addition of a 5 nm titanium coating (80 s at 0.63 Å/s) on top of the silicon dioxide. 
Atomic Force Microscopy (AFM) 
AFM of nanoparticles sputter coated with both silicon dioxide and titanium was 
performed at the University of Denver using an Asylum Research MFP-3D instrument 
with AR v13 software (Bruker probe MSNL-10, Figure 25). Image analysis and 
measurements were done with Gwyddion software. 
AFM was also done with a Bruker Resolve instrument located at Colorado State 
University in Fort Collins, CO. For these experiments, a ScanAssyst Air probe was used 
and analysis was done with Nanoscope Analysis 1.8 software. Samples tested had 30 nm 
silicon dioxide and 5 nm titanium sputter coating (Figure 25) or no sputter coating at all 
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(just melted nanoparticles, as seen in Figure 26). Gwyddion software was used to 
calculate the roughness of the sputter coated flat region. 
Cell Culture Experiments 
PC-12 gr5 cells (ATCC) were grown in T-25 or T-12.5 flasks (Nunclon) with 
Dulbecco’s Modified Eagle Media (Life Technologies 11965) containing 5% fetal calf 
serum (Fisher SH3007403), 5% horse serum (Fisher SH3007203), and 100 µg/mL each 
of penicillin and streptomycin (Fisher ICN1670049). Cells were split or plated when at 
80% confluence with pipetting up and down to break up clumps. Versene (Thermo Fisher 
15040066) was used to detach cells from flasks. Polylysine (Sigma PL4707) was used to 
coat the coverglass with an incubation time of 20 min at room temperature. Coverglass 
was then washed 3 times with sterile PBS (Life Technologies 14040) prior to plating 
cells. Cells were allowed to adhere and grow overnight. Manufacturer’s instructions were 
followed to stain membranes with Cellmask in green or deep red (Life Technologies 
C37608 or C10046). 
Supported Lipid Bilayer Analysis 
The protocol used here was modified from a previously published method (8) and 
a detailed version of that protocol can be found in Appendix A. The modifications 
included no Hellmanex and no deposition of nanoparticles (already deposited and sputter 
coated). Each experiment starts with washing the sputter coated substrate with buffer (15 
mM HEPES, 100 mM sodium chloride, 2 mM calcium chloride, pH 7.4). If using 
customized chambers, the volume used in the working volume listed above or a volume 
of 500 µL, if using only the Attofluor chamber. Lipid incubation and rinsing off 
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liposomes is also the same except for the volumes being chamber size dependent. After 
imaging is over, wells are cleaned for reuse. Cleaning steps include removal of lipid-
buffer solution, incubating with the appropriate maximum volume of 1% SDS for 5 
minutes, and washing 3-4 times with deionized water. Wells are left empty, allowed to 
dry, and stored in an individual covered and labeled container for later use. The 
containers that were found to work well are two small weigh boats taped together to form 
a clam shell configuration. Lipid structures in the compositions used here are illustrated 
below. Lipid film compositions contained 92-98% POPC, 0-5% cholesterol, 0-1% 
DOPE-PEG 2000 and 2% MB-DHPE or 2% Fluorescein DHPE (FL-DHPE). All lipids 
were purchased from Avanti Polar Lipids, with the exception of MB-DHPE and FL-






Figure 23. Lipid Structures. A) POPC, B) Cholesterol, C) PEG-DOPE, D) MB-DHPE, E) FL-
DHPE 
Confocal Microscopy 
A point-scanning confocal microscope (Olympus Fluoview FV1000) was used for 
cellular experiments. For two-color imaging, the red and green fluorescence were taken 
sequentially to reduce bleedthrough with a 100× oil objective such that one pixel was 
equal to 99 nm. The red channel was excited with a 559 nm laser with an emission 
window of 575−675 nm. The green channel was excited with the 488 nm laser with an 
emission window of 500−545 nm.  
Another point-scanning confocal microscope (Olympus Fluoview FV3000) was 
used for the supported lipid bilayer experiments. For two-color imaging, the red and 
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green fluorescence or red and blue fluorescence were taken sequentially to reduce 
bleedthrough with a 100× oil objective such that one pixel was equal to 99 nm (zoom 
2.5). The red channel was excited with a 559 nm laser with an emission window of 
575−675 nm. The green channel was excited with the 488 nm laser with an emission 
window of 500−545 nm. The blue channel was excited with a 405 nm laser and emission 
was detected from 425 to 475 nm. 
Data Analysis 
Confocal images were split by channel and exported into TIFF files using ImageJ 
(http://imagej.nih.gov/ij/) or Olympus FV FV31S-SW software. Detailed steps for 
colocalization analysis in MATLAB are outlined in Appendix D. Colocalization analysis 
of non-cell nanoparticles resulted in false positive curvature sensing, so the second 
method outlined in Appendix D was used for cell data. Fluorescence recovery after 
photobleaching (FRAP) analysis employed the method outlined in Appendix B. 
4.3 Results 
Using a combination of already established methods, a reuseable nanoparticle 
patterned substrate was made (8, 9, 129, 130). In order to induce curvature into cells for 
studying proteins that go to sites of curvature, it was first necessary to have an assay that 
allowed cells to grow on top of a patterned surface. Initial attempts to grow cells on top 
of melted nanoparticles resulted in cellular uptake of the fluorescent nanoparticles 
(Figure 24A). By sputter coating the melted nanoparticles with 30 nm of silicon dioxide 





Figure 24. Cells invaginate melted nanoparticles prior to sputter coating. A) PC12 cells grown 
on top of melted nanoparticles show fluorescence in the z-stack of the nanoparticle channel. B) 
PC12 cells grown on top of melted and silicon dioxide sputter coated nanoparticles have a 
distinct layer of fluorescence along the coverslip of the nanoparticle channel. C) The 
corresponding z-stack for the Cellmask channel highlighting the cell membrane. 
AFM was used to determine the size and shape of the melted and sputter coated 
nanoparticle pattern substrate. The titanium sputter coat was added to enhance the ability 
of the AFM probe to sense the surface in tapping mode (Figure 25). Data contains a large 
amount of noise. Line scans indicate widths of 300-400 nm and heights of 80-300 nm. A 
Confocal AFM instrument was used to measure sizes of melted nanoparticles with no 
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sputter coating resulting in heights of 70-80 nm for the melted 100 nm nanoparticles 
(Figure 26). This same instrument was used to measure the roughness of flat region after 
30 nm silicon dioxide and 5 nm titanium coatings. The majority of the roughness values 
are within ±10 nm (Figure 27).  
 
Figure 25. Atomic force microscopy (AFM) of melted and sputter coated nanoparticles. 100 nm 





Figure 26. AFM results for melted nanoparticles. Nanoparticles start out as 100 nm Fluospheres 
and have a height near 70 nm after melting. 
 
 
Figure 27. Calculated roughness of 30 nm silicon dioxide and 5 nm titanium coated glass 
coverslip flat region from an AFM image. 
Initial results from colocalization analysis with cellmask membrane staining 
appeared to show colocalization of membrane material with sites of curvature. This is 
expected due to the increase of surface area if the membrane wraps around the curved 
region (data not shown). After analyzing a control, it was discovered that this was a false 
positive due to the bright regions around the edges of the cell image. By only analyzing 
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the nanoparticles on the inside of the cells, the reprocessed data shows a lack of curvature 
sensing by the cell membrane (Figure 28, Appendix D). 
 
Figure 28. Representative radial average of colocalization analysis of PC12 cell membranes 
labeled with cell mask on top of sputter coated, melted nanoparticles. 
For an in vitro analysis of the ability for membranes to curve around the 
nanoparticle patterned substrate, supported lipid bilayers were used with combinations 
that contained cholesterol and a polyethylene glycol (PEG) polymer attached to the lipid 
head group (Figure 23). PEG was added to mimic the extracellular matrix, which has an 
impact on membrane dynamics (131). Cholesterol was added to mimic cellular 
membranes. Cellular membrane composition varies by cell type, leaflet side, and even 
regions of the cell (Figure 29 and Figure 30). One example of this variation has been 
recorded by others with two opposite sides of an intestinal cell (apical and basolateral) 
containing different compositions (132). The phospholipid type as well as the amount of 




Figure 29. Plasma membrane composition of two regions of intestinal cells are representative of 
the variation among cell membrane compositions and the high amount of cholesterol present 
(132). 
Table 5. Lipid and cholesterol compositions vary with cellular organelles (133). 
 % of total phospholipids Ratio 
Membrane PC PE PI PS Chol/PS 
Endoplasmic reticulum 55 30 15 3–5 3 
Golgi complex 50 15 10 5 4 
Early endosome 47 23 8 8.5 - 
Late endosome 48–49 18.5–20 4–7 2.5–3.9 - 
Mitochondria 40–46 30–35 5–10 1 10 
Plasma membrane 42 25 3 12 8 
 
Fluorescent lipids were used to visualize membranes for colocalization. FL-DHPE 
has been shown by others to sense curvature and MB-DHPE was used as our control 
(118). Radially averaged colocalization data was normalized to an average of the tail 
region (0.75 µm or farther away from the center of the pixel). Results show that the lipid 


















Figure 30. Colocalization analysis of fluorescent lipids in a supported lipid bilayer deposited on 
melted, silicon dioxide coated nanoparticle patterned surface. X-axis on all graphs shows the 
distance from the center of the nanoparticle. Y-axis data shows the radially averaged intensity for 
pixels falling within that distance from the center of the nanoparticle. A) Lipid films made with 
93-98% POPC, 2% MB-DHPE, 0 or 5% cholesterol, and 0 or 1% PEG-DOPE. B) Lipid films 
made with 93-98% POPC, 2% FL-DHPE, 0 or 5% cholesterol, and 0 or 1% PEG-DOPE. C) 
Comparison of the two fluorescently dye labeled lipids with membranes that contain PEG and 
those that do not. Each data set is 3 or more experimental days, N=3-5 for SEM. Total number of 
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particles for each data set are: 1307 for MB, 721 for MB.Chol, 714 for MB.PEG, 1082 for 
MB.Chol.PEG, 1921 for FL, 889 for FL.Chol, 2251 for FL.PEG, and 4380 for FL.Chol.PEG. 
Preliminary results from FRAP data analysis shows that fluid membranes are 
possible with the silicon dioxide coated nanoparticles. Diffusion constants for each lipid 
composition were calculated from the FRAP recovery curves (Figure 31 and Figure 32). 
 
Figure 31. FRAP recovery curves and diffusion constants for lipid membranes containing MB-
DHPE deposited on top of 100 nm melted, silicon dioxide coated nanoparticles. Diffusion 
(represented as D) units are μm2/s. Each recovery curve is from 3 experimental days and the 
following number of images: A) N = 10, B) N = 11, C) N = 7, D) N = 8. 












































































Figure 32. FRAP recovery curves and diffusion constants for lipid membranes containing FL-
DHPE deposited on top of 100 nm melted, silicon dioxide coated nanoparticles. Diffusion (D) 
units are μm2/s. Each recovery curve is from 3 experimental days and the following number of 
images: A) N = 10, B) N = 10, C) N = 6, D) N = 10. 
4.4 Discussion 
This chapter shows three key advances for our membrane curvature biosensor 
assay. The first and second key advancements were to create a fixed and reusable 
nanoparticle substrate through annealing and sputter coating the nanoparticles. The third 
advancement was the addition of chambers to allow for smaller experimental working 
volumes.  









































































A fixed substrate was done by sputter coating fluorescent nanoparticles patterned 
onto a glass coverslip. This process merged two current protocols to melt and coat 
fluorescent nanoparticles as seen in Figure 22 (8, 129). The permanence of the patterned 
substrate not only allows for washing and reusing them, but also applications of lipid 
bilayer and cellular membrane experiments. Due to the slightly larger well area and the 
more permanent nature of the 3D printed chambers, they are preferable to the smaller 
silicone rubber chambers (Figure 21). Furthermore, the pink colored silicone rubber 
caused scattering in the red channel with epifluorescence imaging, making it difficult to 
focus in the eyepiece. Black colored silicone rubber was then used and did not have 
scattering. The versatility of being able to 3D print chambered wall system in the size and 
shape needed for the experiment and having the ability to use plain coverglass or 
nanopatterned coverglass make this a desirable system. 
The AFM data from the University of Denver instrument contained a large 
amount of noise, however the images do indicate the relative distances between 
nanoparticles and although clumps do exist, that the majority of nanoparticles are 
separated (Figure 25). Furthermore, the larger size for the titanium sputter coated 
nanoparticles indicates that the AFM probe in tapping mode interacts widely with the 
metal. This was added for the purpose of increasing the AFM interaction, since earlier 
experiments with AFM on melted nanoparticles had failed to produce any images 
showing the nanoparticles (not shown here). The opportunity to use the AFM at Colorado 
State University allowed for a more accurate measurement with a suitable height of 80 
nm for a melted nanoparticle (Figure 26). 
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One use for this assay is to determine the curvature sensing ability of different 
lipid compositions and probes. FL-DHPE has been shown by others to prefer curvature 
and was used as our positive control (118). MB-DHPE is not expected to prefer regions 
of curvature over flat regions. The more a lipid membrane curves around a nanoparticle 
patterned region, the higher the intensity. Unless a lipid completely avoids curvature, it is 
expected to have a slight increase in intensity around the nanoparticle due to an increased 
surface area (established in Chapter Three). As seen in Figure 30, MB-DHPE has a 
smaller normalized intensity at the center of nanoparticles than FL-DHPE. This matches 
the expected results of others for FL-DHPE to sense curvature.  
The proposed experimental design was to test whether or not the addition of 
cholesterol or a lipid with a PEG head group would affect that curvature sensing. As seen 
in Figure 30A, the addition of PEG to a membrane decreases the intensity near the 
nanoparticle. This is most likely due to the size pushing it away from the surface and 
having less surface area to interact with the nanoparticle. Figure 30A also shows that the 
addition of cholesterol to membranes with or without PEG has the same effect – to 
increase the ability to sense curvature. It can be envisioned that the small size of the 
cholesterol would help lipid packing around nanoparticles. When comparing the same 
addition of cholesterol or PEG to membranes with FL-DHPE (Figure 30B), it appears 
that cholesterol does not affect the curvature sensing of a lipid that already has that 
ability, however, PEG still decreases the curvature sensing. The decrease in the ability of 
PEG to sense curvature can be applied as a mimic of the extracellular matrix and 
therefore cells would be expected to have a certain size of sputter coated nanoparticle 
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pattern that would no longer induce curvature in the membrane, but instead would grow 
the same as a flat membrane. This idea is supported by other research where micro-scale 
and nano-scale patterns affects cell growth differently (134, 135). 
4.5 Summary 
In this section, we have shown how the addition of a 30 nm silicon dioxide sputter 
coating to a nanoparticle patterned surface allows for cell growth without invagination of 
the nanoparticles. This sputter coating still had curved regions, as seen by the sensing of 
curvature with the colocalization analysis radial average results. The bilayers were also 
able to be bleached and recover, indicating that a fluid bilayer can form on top of the 
silicon dioxide coated nanoparticles. Overall, the addition of PEG to a membrane 
decreased its ability to sense the curvature. The fabrication of chambered systems to 
attach to the nanopatterned surface added the convenience of multiple experimental 
conditions to be tested at one time with lower volumes. Lastly, the ease of producing and 
reusing a 3D print chambered system and its cost-effectiveness will allow it to be applied 









CHAPTER FIVE: CONCLUSION AND FUTURE WORK 
CRP biochemical research in this work showed significant C1q binding for mCRP 
made with 0.01% SDS and heated for 1 hour at 80 °C and for mCRP made with 1.5 M 
GndHCl. 7 M urea treated CRP showed some C1q binding, however, it was not 
significant compared with BSA binding. Structural analysis with Chimera software 
complimented the use of circular dichroism as well as intrinsic tryptophan and ANS 
fluorescence to analyze the various denaturants used. The transition from pCRP to mCRP 
was clearly seen on non-denaturing PAGE and with intrinsic fluorescence. Furthermore, 
the denaturation curve for GndHCl was used to calculate the Gibbs free energy of 
unfolding for CRP. 
The outer leaflet of apoptotic cell membranes was mimicked using a 
nanopatterned substrate to create curved, supported lipid bilayers and then used to 
characterize how CRP conformation affects the interactions between CRP and target 
membranes. In this assay, the chemical composition and shape are separately tunable 
parameters. The lipids consisted primarily of palmitoyl-oleoylphosphatidylcholine, with 
and without lysophosphatidylcholine, and the curvature had a radius of 27−55 nm. Using 
this model system combined with quantitative fluorescence microscopy methods, CRP 
binding to lipid membranes was measured as a function of different conformations of 
CRP. The modified form of CRP bound curved membranes, but the pentameric form did 
not for the range of curvatures measured. Unlike most other curvature-sensing proteins, 
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modified CRP accumulated more at a moderate curvature, rather than highly curved or 
flat regions, suggesting that the membrane bound form does not solely depend on a defect 
binding mechanism. The presence of lysophosphatidylcholine, a component of apoptotic 
membranes, increased CRP binding to all types of membranes. Overall, our results show 
that CRP interactions vary with protein form, lipid composition, and membrane shape. 
The mechanism by which CRP recognizes damaged membranes depends on the 
combination of all three. 
The final section of this work illustrates the advantages of a sputter coated 
nanopatterned substrate for both repeated use and for the versatility in applications from 
supported lipid bilayers to cells. Experimental options were added and imaging was 
facilitated by the addition of chambers (either cut silicone rubber or 3D printed PETG 
plastic). These chambered nanopatterned systems are reusable and reduce the 
experimental volume. Error bars from supported lipid bilayer experiments show 
consistency between days for reusing these systems. Results from colocalization analysis 
to check for curvature sensing indicates that the addition of cholesterol to membranes 
increases its ability to sense curvature and the addition of a lipid with a PEG attached to 
the head group decreases the ability for a lipid mixture to sense curvature. 
Future research to further understand and characterize this system includes the 
analysis of both cellular and supported lipid bilayer membranes with different sizes of 
nanoparticles and creating an eight well 3D printable chamber for attachment to a 24 x 50 
mm 1.5 coverglass plate. Initial testing of this coverglass size worked well with confocal 
imaging. Finally, along with publication, the files for the 3D printable chambers will be 
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made available on the NIH 3D print exchange website. Further analysis of FRAP of 
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APPENDIX A: SUPPORTED LIPID BILAYER ON NANOPARTICLE 
PATTERNED SUBSTRATE 
This protocol is a detailed version (with troubleshooting tips) of the one outlined 
by Black, et al (8). 
Detailed instructions 
Preparation and Supplies Needed 
1. Use an 8 well chambered coverglass that has been pre-cleaned in advance by doing 
the following (#1.5 coverglass is preferred if doing sensitive assays due to better 
microscope images; #1 coverglass is less expensive – be consistent within an 
experiment): 
a. Cover with 0.1% SDS in a beaker - soak for 1 hour (usually 4-6 coverglass 
plates) 
b. Pour off SDS and cover with 1% Bleach solution in a beaker - soak overnight 
c. Pour off bleach and change solution to Millipore water (make sure it is 
covering the plates). Rinse 2-3 times with water. This is what they will be 
stored in until an experiment is performed. 
2. Use lipids (PC, PS, etc.) that have been prepared at DU by the following method: 
a. Lipids and dye labeled DHPE are combined with percent by mole. Total aim 
should be 250 nanomoles. Using the molarity (M) of PC, PS, or dye labeled 
(MB or TR) DHPE calculate the μL of each to add to the vials. 
b. Normally 6-8 vials are made at a time. Cover with foil and label each vial on 
the sides and top. 
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c. Glass syringes that are used with chloroform are not to be used with anything 
else (the syringes are labeled “Heather Syringe” or for S.P.T. only – SPT are 
NOT to be used with red lipids). 
d. Under the hood, measure out appropriate amounts for each dye/lipid, going 
from smallest to largest volume. Rinse syringe 5+ times with chloroform 
between/after use. Using the largest volume, swirl vial to mix lipids. 
e. Place open vials in vacuum, seal, and make sure hose path is correct, turn on 
and wait for bubble noise to stop, reposition stop-cock to create vacuum. 
Leave overnight. Clean up lipid stock by quickly blowing solution with argon 
or nitrogen to remove any oxygen from stock solution. Screw on lid and wrap 
with electrical tape. 
f. Turn off/remove vials from vacuum. Cover lipids with nitrogen. Screw on lid 
and store in freezer. 
3. Nanoparticles (if applicable) are found in the refrigerator – we usually use red 
fluorescent polystyrene fluorospheres (Invitrogen) 
4. Protein (C1q or CRP) and applicable antibodies if not using labeled protein 
5. Buffers/Solutions: 
a. 30 mM PIPES, 2 mM CaCl2, 140 mM NaCl, pH 6.4 





Experiment Day Procedure 
Note: Plan out 8-well grid before doing experiment (or while soaking with Hellmanex) 
All experiments should be done with a directional indicator on the wells. The #1 
plates have the word “LAB” on one side that you can place in the upper left. The #1.5 
plates have a notch that can be placed on the left. 
 
1 3 5 7 
2 4 6 8 
 
 
1. Using a Kim wipe or paper towel, dry off the 8 well chambered coverglass 
2. Add 100 μL of Hellmanex to each well, cover with lid and let sit 1 hour (at R.T.) 
3. If doing nanoparticles: 
a. Dilute with PIPES buffer (see concentrations below) 
i) Optional bath sonication for 15 minutes after 1st dilution to break 
up clumps as needed 
ii) 40 nm size dilute 1 μL with 999 μL (10^3), and sonicate for 15 
min, then dilute 1 μL of 10^3 solution with 999 μL of PIPES 
again (10^6 dilution total) 
iii) 100 nm size dilute 1 μL with 999 μL (10^3), and sonicate for 15 
min, then dilute 100 μL of 10^3 solution with 900 μL of PIPES 
again (10^4 dilution total). 
iv) 500 nm size dilute 1 μL with 999 μL (10^3), 







c. Rinse 3 times with 100 μL of PIPES buffer 
d. Add 100 μL of nanoparticle solutions, cover with foil and incubate at r.t. for 
30 minutes 
4. Lipids 
a. Prepare each lipid solution by adding 2 mL (or 2000 μL) of PIPES buffer to 
each lipid mixture vial that was prepared above (vacuum, nitrogen, etc.) 
b. Sonicate for 5 minutes with the probe sonicator on “2” setting (sand probe 
lightly with sandpaper if it has not been done in a while, and clean with 
ethanol before each use) 
c. Empty wells using 100 μL pipette (removing solution from wells, but leaving 
nanoparticles) 
d. Add 100 μL of appropriate lipids to each well. 
e. Cover with foil and incubate at 37 °C for 1 hour 
5. Proteins (note if not using proteins, follow step c to remove liposomes before 
imaging) 
a. Thaw in ice bucket 
b. Calculate amount of protein to add to each well to get desired concentration: 
either labeled (different concentration) or purchased protein. 
c. Rinse 3 times with 100 μL of PIPES buffer (adding lipids first, then remove; 




d. Add predetermined amount of protein and incubate for 1 hour at r.t. (Aml 
does CRP for 2 hours at 37 °C; some proteins, can be incubated for 10-15 
minutes) 
e. If using antibodies: pre-incubate primary and secondary together in 1:1000 
ratios for 30 minutes (covered with foil at r.t.) 
f. Add 100 μL of pre-incubated primary and secondary antibody to each well. 
Cover with Foil and incubate for 30 minutes. 
6. Image on Confocal or TIRF microscopes. Recording settings as needed. 
7. Putting data into folders for each well is useful. Name files with contents of well for 
future reference. The illustrations below show how different students number the 
wells. Whatever you do, be consistent! 
Carrie: 
1 3 5 7 
2 4 6 8 
Aml: 
8 7 6 5 
4 3 2 1 
Alan:  
1 2 3 4 





Troubleshooting and notes by steps 
1. Cleaning plates: 
a. Plates should be used within 2 weeks of cleaning or a small amount of 
sodium azide to the water should be added to prevent contamination with 
bacteria. 
2. Hellmanex: 
a. Do not keep Hellmanex on for more than 1 hour, it will start to dissolve 
the glue and cause the well to leak/break. 
b. If a well looks empty after the 1 hour, it most likely had a leak to begin 
with. Fill it with 100 µL of buffer and see if it empties out. If it does not 
stay full, you cannot use that well for the experiment. 
3. Nanoparticles: 
a. The first dilution of NPs (103) can be reused if stored in the refrigerator 
and shaken gently to resuspend prior to the second dilution. 
b. Do not keep foil on the tube when bath sonicating, the foil will break up 
with the sonication. Bath sonication is optional. Too much bath sonication 
appears to break up NPs and cause problems. 
c. NPs can be incubated for a longer period of time if needed, it will just 
increase the number of NPs that settle on the surface. 
d. Adding NPs and lipids at the same time causes NP islands to be formed 
above and below lipids. 
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e. An older batch of 100 nm red NPs was the reconstituted, so if using, the 
second dilution works best at 30 μL of the 103 solution with 970 μL of 
PIPES. 
4. Lipids: 
a. Lipid incubation time can be up to 2-3 hours at 37 °C. 
b. Incubating lipids at room temperature results in non-fluid bilayers. 
c. Failure to wash three times after lipid incubation keeps liposomes on the 
surface. 
d. Care should be taken when washing to only place the tip in one corner of 
the well and to keep the tip from touching the bottom of the coverslip (tip 
should be in the buffer). 
5. Protein: 
a. If the protein is in the freezer, be sure to allow at least 30 minutes prior to 
the end of lipid incubation to thaw it on ice. 
b. If using antibodies, pre-incubate when 30 minutes are left for protein 
incubation. 
6. Imaging: 
a. If there is extra time before scheduled imaging, finished coverslips can be 
stored covered with foil at 37 °C or room temperature for 1-2 hours. 
b. Multiple channels should be imaged on the confocal sequentially by line 
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APPENDIX B: FRAP DATA ANALYSIS 
This is a detailed protocol for the correction and analysis for Fluorescence 
Recovery after Photobleaching (FRAP) data from the confocal microscope and was 
modified from a protocol written by Alec Feuerbach. 
Correcting for overall photobleaching 
1. Open FRAP image (.oib from Confocal; if saved on newer Confocal as .oir file, 
convert to .oib in Fluoview software) in ImageJ (http://imagej.nih.gov/ij/) 
2. Click on the ROI to display it or if it is not displayed, create an ROI where the bilayer 
was bleached. 
 
3. Collect intensity data for the FRAP ROI over the whole series by clicking the 
following in the “ROI Manager” window: 
a. More 
b. Multi-Measure 




e. Results appear in a new window 
 
4. Transfer data to Excel: 
a. Open Excel 
b. In the Results window in ImageJ do: 
i. Edit 
ii. Copy 
c. Go to cell D3 and Paste 
d. Fill out the D2-H2 cells with the appropriate heading and write 




5. In ImageJ, move the ROI to another region away from the bleached area in order to 
measure the background intensity/bleaching 
 
6. Click “Add” in the ROI Manager to add the region of interest that you want to 
measure and select the new ROI before measuring the ROI. 
7. In the “Results” window do: 
a. Edit -> Select All 
b. Edit -> Clear 
8. Repeat steps 3 and 4, with the exception of pasting the data in J3 and putting the title 




9. The excel spreadsheet should now look like this along the top: 
 
10. Get a photobleaching correction value for the background (random) ROI by dividing 
the intensity of the first slice by each slice intensity (in cell P3, the equation 
=$L$3/L3 is entered and dragged down the column to fill in the equation). Numbers 
should start with 1 and get larger. 
 
11. In A1 type “Corrected FRAP Data” and in A2 type “Time (sec)” 
a. In ImageJ, find the frame interval by going to Image -> Properties 
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b. In Excel, in cell A3 use the formula =(D3-# of frames to 
activation)*(frame interval). Note the # of frames to activation is 
the preactivation +1. In the case of a preactivation of 3, the number 
used is 4. The lowest intensity will line up with Time= 0. 
c. Drag to fill formula 
 
12. In B2, type “Corrected Avg Intensity” (or Mean) 
13. Multiply the average (mean) intensity of each slice from the FRAP ROI (Column F) 
by the Correction value for that slice (Column P). To do this B3 will have =F3*P3. 
Drag/fill this formula for all slices. This should give a corrected value for bleaching 
that occurs on the entire image while doing long periods of time for FRAP.  
 
 
14. Save and Copy/Paste this data into a GraphPad Prism XY plot. 
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Plotting Recovery Curves and Calculating Diffusion Coefficients 
 The directions in this section are for using GraphPad Prism to fit the following 
equations for fitting FRAP data and calculating diffusion coefficients (8). 










Where F0 is the initial fluorescence and F∞ is the fluorescence at equilibrium. K is the rate 
constant and t is time in seconds. D is the diffusion coefficient in μm2/s. γD is defined as 
0.88 for a circular beam and τhalf is the time at 50% recovery. For the experimental data 
processed here w is the radius of the bleaching region of interest (ROI) in μm. 
The first step is to normalize the corrected data in the XY data table in GraphPad 
Prism. To do this, click on the analyze button from the menu along the top and select 
normalize. Define 0% as the smallest value and 100% as the first value. Choose to 




Next calculate the Mean and SEM of the normalized data by selecting Analyze and then 
Row Stats. 
In the Analysis box click: fit with non-linear regression curve and select the “Diffusion 
Coefficient from FRAP recovery curve” equation or add the following as a custom 
equation: 
 Equation: Y=Y0 + (Plateau-Y0)*(1-exp(-K*x)) 




The transforms to report section is where the diffusion constant calculation will need to 
be adjusted for different bleaching ROI sizes. The table below gives some examples of 
confocal zooms with their corresponding pixel resolutions and different radii. 
Zoom with 100X objective nm/pixel Radius for ROI 
1X 240 15.5 μm for 125x125 pixel tornado 
2X 124 7.75 μm for 125x125 pixel tornado 
2.5X 100 6.25 μm for 125x125 pixel tornado 
2.486 μm for 50x50 pixel tornado 





When fitting the data, if X values greater than 0 are included in the fit, there will be an 
error. This can be fixed by adjusting the range, as shown below. 
 
Diffusion constants can now be seen in the results and a corresponding graph with the 




APPENDIX C: NON-DENATURING PAGE AND SILVER STAIN PROTOCOL 
The non-denaturing polyacrylamide gel electrophoresis protocol has been 
modified from standard Laemmli conditions (68). The silver stain protocol was taken 
from the laboratory notebook of Kathryn Palma, a former student who worked in Dr. 
Knowles’ lab at the University of Denver. Nature protocols has two journal articles for 
silver stain protocol with detailed explanations for the steps (136, 137). 
Non-Denaturing PAGE 
     
1/20th SDS   
Running Gel 10.0% 
(mL) (µL)   
Combine the following: 
4.1667 4166.7 30% Acrylamide 
3.1250 3125.0 1.5 M Tris-HCl pH 8.8 
0.0063 6.25 10% SDS 
5.0646 5064.6 (to add up to 12.5mL) Water 
0.1250 125.0 10% APS (Ammonium Persulfate) 
Swirl to Mix   
0.0125 12.5 100% TEMED 
Swirl to Mix   
Pour & let set 10-20 min (put thin layer of ethanol on top) 
     
Stacking Gel 3.2% 
(mL) (µL)   
0.2667 266.7 30% Acrylamide 
0.3125 312.5 1 M Tris-HCl pH 6.8 
0.0013 1.25 10% SDS 
1.8646 1864.6 (to add up to 2.5mL) Water 
0.0500 50.0 10% APS (Ammonium Persulfate) 
     
0.0050 5.00 100% TEMED 
Swirl to Mix   
Pour & let set 20 
min   
Store in Ziploc bags in fridge, wrapped in paper towels, 




Silver Stain of Native PAGE Procedure 
Make the following solutions (filling to total volume with diH2O): 
• Fixing Solution (50 mL total) 
o 25 mL of Methanol (final = 50%) 
o 2.5 mL of Acetic Acid (final = 5%) 
o 25 µL of 37% Formaldehyde (final = 0.0185%) 
• 50% Methanol (2 × 50 mL total, 25 mL of methanol in each) 
• 10% Sodium Thiosulfate (Na2S2O3)-need 150 µL minimum (good for 1 week) 
o equivalent of 10 g/ 100 mL or 10 µg/ 100 µL 
o _______ mg x 10 = ________ µL 
• Sensitizing Solution (25 mL total) 
o 50 µL of 10% Sodium thiosulfate (final = 0.02%)  
• Silver Stain (25mL total) 
o 50 mg Silver Nitrate – AgNO3 (final = 0.2%) 
• Developer (25mL total) 
o 50 µL of 32% Formaldehyde (final = 0.074%) 
o 1.5 g Sodium Carbonate (Na2CO3) (final = 6%) 
o 100µL of 10% Sodium Thiosulfate (Final = 0.04% 
• Stopping Solution (50 mL total) 
o 25 mL Methanol (final = 50%) 




Use 25mL for each step below (except step 8): 
        1. Fix (rock in fixing solution) 2×15 min 
        2. Wash 3×8 min with 50% Methanol 
        3. Sensitize 60 sec 
        4. Wash 2×20 sec diH2O 
        5. Silver stain for 30 min 
        ► Place waste in appropriate container 
        6. Wash 2×30 sec diH2O 
        7. Develop until bands show 
        8. Add stopping solution (50mL) 
                Swirl until no more bubbles 
        9. Wash 10 min with 50% Methanol 
        10. Final rinse diH2O 




APPENDIX D: COLOCALIZATION MATLAB ANALYSIS 
The steps for MATLAB analysis of microscopy images for colocalization are 
outlined below. This chapter also includes directions for removing non-cellular 
nanoparticles when looking for colocalization between nanoparticles and cell membranes. 
The MATLAB code used for the data analysis is included at the end. The majority of this 
code was written by Dr. Michelle Knowles, Mitchell Alton, or Dr. Philip Cheney. 
 
Data Analysis 
1. Open Olympus Fluoview FV31S-SW 
a. File > Export Multiple Files 
b. Select folder create new “Exported Images” subfolder for saving files 
c. Select no overlay 
d. Output format: Raw Data Extracted, 16-bit Gray Scale, no compression 
e. This will save each image in its own folder and each channel as separate 
image file 
2. Open MATLAB 
a. Find the folder with the image files using the window on the left side of 
the screen 
b. Type run_ministk in the command window and press enter 
i. Choose the red and green channel images 




3. If needed, cut out saturated pixels: 
a. Open the folder that has the *.stk images in MATLAB (Alternatively, 
open a parent folder and search for .stk and then select each one with 
CTRL help down and then copy/paste into a new folder named “blue 
stacks” or “green stacks”. This is useful for large numbers of stacks to be 
easily processed.) 
b. Type cutout_saturated in the command window and press enter 
c. Choose the file that you want to remove saturated slices from 
d. Save the unsaturated image 
4. Use ImageJ to concatenate all of the images from a single well for the day 
a. Open all of the stacks you want to concatenate 
b. On the ImageJ toolbox, click the Stk button and then ‘Delete Slice’ to 
delete the first black slice on each stack 
c. Then click the Stk button again and click concatenate and select all the 
open files on the window that pops up 
d. Save as > tiff 
e. Save average of the concatenated stack (to use below) 
f. Repeat Concatenation for every day of the experiment with those settings 
5. To get the radial average, type the following into MATLAB (with the folder open 
in MATLAB), changing the red text for the file name(s) as needed (you can have 








If you forget to change the name in the xlswrite part of the code, then you can rename it 





Removing Non-Cell Nanoparticles from Images 
1. Open oib file in ImageJ 
2. File > Save As> Image Sequence (new folder for image sequence) 
3. Open newly saved .tiff of CellMask (green) channel 
4. File >Save As> Tiff – type 8 bit after the name 
5. Image > Type> 8 bit 
6. Image > Adjust > Threshold (this should highlight the cell/fluorescent regions 
only – the cutoff values can be adjusted in the window that pops up). 
7. Edit > Selection > Create Selection (to get threshold highlighted region outlined) 
8. Analyze > Tools > ROI Manager to open the ROI Manager 
9. In the ROI Manager, after clicking on the cell mask image click “Add” 
10. Open the Nanoparticle .tiff saved in step 2 
11. Click on the ROI listed in the ROI manager so it is displayed on the image 
12. If some regions that were highlighted are from the background/not clean (most 
likely), select the following in the ROI manager: More > Split 
13. There should now be a large number of ROIs listed (usually hundreds). To find 
the wanted ROIs, make sure Show all and Label are both checked. This will allow 
you to click on the ROI you want and find it in the list. The ROIs are listed in 
order of left to right, top to bottom from the lowest part of the ROI. Try to select 
the top cell region first and then click on one ROI up above it and hold down 
shift. Using the mouse, scroll to the top and click on the 2nd ROI (the first should 
be the entire original ROI). Then hit “Delete”. Continue to do this or to school 
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with the arrows on the keyboard and delete all the unwanted ROIs. This should 
leave you with 1-4 cell area ROIs. 
14. Select each cell ROI (not the top one that was the original with everything) and go 
to: More > Or (combine) 
15. The cell regions that you want to keep should now be selected in the NP channel 
16. In the main menu: Edit > Clear Outside 
17. File > Save as > Tiff > add “Noncell NPs removed” to the file name. 
18. Delete all the ROIs left in the ROI manager after you close the images and then 






function [] = run_ministk ( ) 
  
%ask for red and green channels 
[redfile,redpth] = uigetfile('*.tif','Select the Red Channel'); 
[grnfile,grnpth] = uigetfile('*.tif','Select the Green or Blue 
Channel'); 
  
%ask where to save the resulting file 
[savefile,savepth] = uiputfile('*.mat','Where to save the Results'); 
  




%view the image, imagesc autoscales. 
colormap('gray'),imagesc(a); 
  
% filter the image, 9 is a size, filter things larger than 9 pixels, 
and filter 1 or smaller 
b=bpass(a, 1, 9); 
colormap('gray'),imagesc(b); 
colormap('gray'),image(b);   
%seems to make a saturated mask like image when using beads 
  
%use the filtered image to find regions. 100 is the threshold and 9 is 
a size of feature  
%you are looking for. Should be the same as above. RECORD THESE NUMBERS 
IN  
%YOUR NOTEBOOK! 
pk=pkfnd(b, 100, 9); 
  
%find centroids -  NOT NEEDED for colocalization routine 
cnt=cntrd(b, pk, 15); 
  
%overlay regions onto non-filtered image. Adjust the threshold to find 




plot(pk(:,1), pk(:,2), 'ro'); 
zoom 
  
%once you like the threshold and want to cut out ministacks 
%do this with both color channels so that you can check it.  
cutout_red = ministk(a, pk, 24, 9); 




%a is the image you will be cropping, pk are the regions you would like 
to crop, 24 (+1)  
%is the size of images you will cut out and if spots are too close 
(within 9 pixels of one  
%another) you will not count either of them.  
  




cutout_red_avg = uint16(mean(cutout_red,3)); 





%see what regions were kept and save them. You do NOT need to do this 
with both  
%image files, since the spot locations will be identical. 
finalspt = keptspot(a, pk, 24, 9); 
save(fullfile(savepth,savefile)); 
  
% you can view what spots were kept and what were ?too close? to others 




plot(finalspt(:,1), finalspt(:,2), 'ro'); 
zoom 
  
%Added by Carrie Moon to save image of which NPs were selected 
hgexport(gcf, fullfile([savefile '-selected-NPspots.png']), 
hgexport('factorystyle'), 'Format', 'png'); 
  
  
%% Make a radial plot of pixel intensity 










%creates matrix of repeating columns of 1 through how ever many columns 
















%creates a matrix of intensities from image 
[THETA,RHO,Z]=cart2pol(x,y,z); 
  




%turns matrix into a list of values 
[t,I,J] = unique(RHO); 
s = zeros(size(t)); 
frequencies = zeros(size(t)); 
for i = 1:max(J) 
    I = find(J==i); 
    s(i) = mean(Z(I)); 




% Save the files 
radialPlot = cat(2,t,s); 
hgexport(gcf, fullfile(grnpth,[savefile '-MB-radial.png']), 
hgexport('factorystyle'), 'Format', 'png'); 










%creates matrix of repeating columns of 1 through however many columns 
















%creates a matrix of intensities from image 
[THETA,RHO,Z]=cart2pol(x,y,z); 
  




%turns matrix into a list of values 
[t,I,J] = unique(RHO); 
s = zeros(size(t)); 
frequencies = zeros(size(t)); 
for i = 1:max(J) 
    I = find(J==i); 
    s(i) = mean(Z(I)); 




% Save the files 
radialPlot = cat(2,t,s); 
hgexport(gcf, fullfile(grnpth,[savefile '-red-radial.png']), 
hgexport('factorystyle'), 'Format', 'png'); 











% PURPOSE:  to cut out small regions of an image based on spots found 
in 
% the image or a corresponding image of a different color. This is used 
to 
% measure colocalization based on the work of Knowles and Barg in two 
PNAS 
% 2011 papers. Spots are found using the work of tracking routines 
% available on Eric Weeks' website (Emory University) and made into 
Matlab 
% by Eric Dufrense. 
% INPUT: 
% im: image to cut from 
% rgn: spots (x,y) about which regions should be cut 
% sz: size of cut out (a square of sz by sz pixels) 
% sepdist: is the minimum separation distance between two spots. If two 
% spots are within this distance of one another, neither are counted. 
% 
% OUTPUT:  a sz x sz x N image array 
%            
% CREATED: Michelle Knowles May 2012 
  
%if sz/2 == floor(sz/2) 
%warning('sz must be even so that the spots can be centered on a pixel: 
1 pixel added'); 
%sz = sz+1 
%end 
  
%scott's code for a mask 
pix=(sz+1)/2; 
dim = length(im); 
nrgn = length(rgn(:,1)); 
  
  
%create a blank image array that you can fill 
msk=zeros([sz+1,sz+1]); 
%loop through all regions that locate spots in an image 
for i =1:nrgn; 
    x = rgn(i,1); 
    y = rgn(i,2); 
    %don't include regions within pix distance from the edge of the 
image. 
    if ((x>pix) & ((x+pix)<dim) & (y>pix) & ((y+pix)<dim)) 
        % don't include regions within "sepdist" pixels of another 
region 
        % calculate an array that contains the difference between the 
        % current particle's position and all others. 
        diffy=rgn(:,2)-rgn(i,2); 
        diffx=rgn(:,1)-rgn(i,1); 
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        mag=((diffx.*diffx)+(diffy.*diffy).^0.5); 
        % find all the locations in the magnitude array that are non-
zero. 
        % This should remove the comparison between particle i and 
itself, 
        % which will always be zero.  
        w = find(mag); 
        mag = mag(w); 
        if (min(mag) > sepdist)   
          cutout = imcrop(im,[x-pix y-pix sz sz]); 
          msk = cat(3, msk, cutout); 
        end 














% PURPOSE:  to remove any images that have an oversaturated pixel. This 
is 
%used to eliminate any error when using this program if saturated 
pixels 
%were mistaken for spots in a previous program. 
% INPUT: 
% stk: stk file to find saturated pixels in 
% OUTPUT:  a sz x sz x N image array 
%            
% CREATED: Mitch Alton 2015 
  
%Phil's code for mask 
  
stk=stkread; 
%choose .stk file from browser 
ind=find(stk>4094); 
%this finds every pixel that has a brightness greater than 4094 
frame=fix(ind/625)+1; 
%divides the pixel number from ind by total number of pixels in one 
image 




%eliminates repeating numbers 
b=1:length(stk); 
%creates list of numbers from 1 to however number of images is in the 
%stack 
b(x)=[]; 




   % listMask(1,list(1,index))=0; 
%end 









function [ avgradial_out ] = make_avgradial(imagestk) 
%loop through better_colo to get a radial plot for each image, then 
average 
%all radial plots. Output average and standard deviation. 
  
dims =  size(imagestk); 
radial = zeros(83, dims(:,3)); 
  
for i = 1:dims(:,3) 
    radial(:,i)=better_colo_V2(imagestk(:,:,i)); 
end  
avgradial_out = zeros(83,3); 
avgradial_out(:,1) = mean(radial,2); 
avgradial_out(:,2) = std(radial,0, 2); 







function  [ radial_out ] = better_colo_V2(a) 
%better_colo plots intensities of a location guided average image as a  
%function of distance from the center of the image.  
%Not needed at the moment but the program does this: The second half of 
the 
%program finds the area under the peak of the radial intensity plot. It 
%does this by subtracting the area of the rectangle under the peak (the  
%peak ends 3 pixels away from the center) using the mean of the data 
after  
%the third pixel as the height of the rectangle.  
%Written by Mitch Alton on 7/1/15 
%adapted for no user input and mass throughput of images by MKK 
9/27/2016 
  
%finds size of the image 
[m,n]=size(a); 
  
%creates matrix of repeating columns of 1 through however many columns 













%creates a matrix of intensities from image 
z=a(1:m,1:n); 
  
%converts three matrixes to a three dimensional polar coordinate matrix 
[THETA,RHO,Z]=cart2pol(x,y,z); 
  




%this averages the intensities (Z) for single distance (RHO) values 
[plt,I,J] = unique(H); 
s = zeros(size(plt)); 
frequencies = zeros(size(plt)); 
for i = 1:max(J) 
    I = find(J==i); 
    s(i) = mean(P(I)); 
    frequencies(i) = length(I); 
end 
radial_out = s.';  
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APPENDIX E: RESOLUTION OF TOTAL INTERNAL REFLECTION 
FLUORESCENCE MICROSCOPE 
Total internal reflection fluorescence microscopy (TIRFm) requires a change in 
refractive index between the glass coverslip and the sample. The TIRFm instrument used 
in the Knowles Lab has two TIRF objectives (60x and 100x). There is a 1.5x zoom that 
can be applied through the microscope and the option of either a dual view or a 2.5x 
optical zoom pathway between the microscope and the camera. The following is a table 
compiled from micrometer measurements taken with the dual view insert at the various 
settings. Dual view values in the table below were divided by 2.5 to get the approximate 
resolution with the dual view removed and the 2.5x zoom attached. 
Objective Zoom DualView? nm/pixel 
60 1 Yes 268.8 
60 1 2.5 107.5 
60 1.5 Yes 180.5 
60 1.5 2.5 72.2 
100 1 Yes 133.0 
100 1 2.5 53.2 
100 1.5 Yes 88.5 
100 1.5 2.5 35.4 
 
Steps for micrometer measurements above: 
1. ImageJ 
a. Open image 
b. Add a scale bar under Analyze > Tools and then save as .jpeg 
c. Open ROI Manager (Analyze > Tools > ROI Manager) 
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d. Draw a rectangle over the area with the micrometer (either lower ½ if dual 
view in or entire image if bypass or 2.5X) 
e. Click “Add” in ROI manager 
f. Select the newly added ROI 
g. More > Multi Plot 
h. Save as a .xls 
2. Excel 
a. Open (select yes) and select Save As and in dropdown select .xls again (states 
the current is tab delimited text), and yes to save over current file by that name 
b. Highlight columns A and B > Insert > Scatter Plot (with lines, not points) 
c. Highlight B > Conditional Formatting > Highlight cell rules > Less than > 
Pick value based on dips in graph (i.e. 400 or 550) 
d. Go through list and highlight in A the cells next to the ones highlighted in B. 
This will display an average in the lower right of the Excel window. Select the 
corresponding X value (pixel distance) and highlight it in orange (or do 2 cells 
if not a whole pixel, i.e. if the average is 5.5, then color 5 and 6). Repeat for 
all the dips and write the average pixel distance above the graph in individual 
wells. 
e. The space between the lines is 10 µm. Take each of the values above the 
graph for the line centers and subtract the consecutive ones from each other to 
get the pixel distance between the lines. Take the average of this (average 
pixel distance for 10 µm). 
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f. Use a formula to do =10000/(average pixel distance) 
 
Sample micrometer image taken with the 60X TIRF objective at 1X zoom with the dual 
view active. 
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